0001553350-16-001790.txt : 20160330 0001553350-16-001790.hdr.sgml : 20160330 20160330092653 ACCESSION NUMBER: 0001553350-16-001790 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160330 DATE AS OF CHANGE: 20160330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOCOPI TECHNOLOGIES INC/MD/ CENTRAL INDEX KEY: 0000888981 STANDARD INDUSTRIAL CLASSIFICATION: GAMES, TOYS & CHILDREN'S VEHICLES (NO DOLLS & BICYCLES) [3944] IRS NUMBER: 870406496 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20333 FILM NUMBER: 161537208 BUSINESS ADDRESS: STREET 1: 480 SHOEMAKER ROAD STREET 2: SUITE 104 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 6108349600 MAIL ADDRESS: STREET 1: 480 SHOEMAKER ROAD STREET 2: SUITE 104 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 10-K 1 nnup_10k.htm ANNUAL REPORT Annual Report

 



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-K


(Mark One)


þ  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the fiscal years ended December 31, 2015


Or


¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ______________________ to __________________________


Commission file number 000-20333


Nocopi Technologies, Inc.

(Exact name of registrant as specified in its charter)


Maryland 

87-0406496

State or other jurisdiction of incorporation or organization 

(I.R.S. Employer Identification No.)


480 Shoemaker Road, Suite 104, King of Prussia, PA  19406

(Address of principal executive offices)  (Zip Code)


Registrant’s telephone number, including area code (610) 834-9600


Securities registered pursuant to Section 12(b) of the Act:


Title of each class 

Name of each exchange on which registered

None 

Not Applicable


Securities registered pursuant to section 12(g) of the Act:


Common Stock $0.01 par value

(Title of class)


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ¨ Yes þ No


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ¨ Yes þ No


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ Yes ¨ No


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). þ Yes ¨ No


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer

¨ 

 

Accelerated filer

¨

Non-accelerated filer

¨ 

 

Smaller reporting company

þ

(Do not check if a smaller reporting company)

 

 


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) ¨ Yes þ No


State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $519,000 at June 30, 2015 closing price of $0.01.


(APPLICABLE ONLY TO CORPORATE REGISTRANTS)


Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. 58,599,016 shares of common stock, $0.01 par value at March 15, 2016.


DOCUMENTS INCORPORATED BY REFERENCE


None

 

 





 


NOCOPI TECHNOLOGIES, INC.

TABLE OF CONTENTS


Item No.

 

Page No.

                   

 

                   

 

Part I

 

 

 

 

1.

Business

1

1A.

Risk Factors

5

1B.

Unresolved Staff Comments

5

2.

Properties

5

3.

Legal Proceedings

6

4.

Mine Safety Disclosures

6

 

 

 

 

Part II

 

 

 

 

5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

7

6.

Selected Financial Data

8

7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

8

7A.

Quantitative and Qualitative Disclosures About Market Risk

14

8.

Financial Statements and Supplementary Data

14

9.

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure  20

14

9A.

Controls and Procedures

14

9B.

Other Information

15

 

 

 

 

Part III

 

 

 

 

10.

Directors, Executive Officers and Corporate Governance

16

11.

Executive Compensation

18

12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

19

13.

Certain Relationships and Related Transactions, and Director Independence

20

14.

Principal Accounting Fees and Services

21

 

 

 

 

Part IV

 

 

 

 

15.

Exhibits, Financial Statement Schedules

21

Signatures

 

22









 


PART I


ITEM 1. BUSINESS


Background


Nocopi Technologies, Inc. (hereinafter "Nocopi", "Registrant" or the "Company") is a Maryland corporation organized in 1983 that currently develops and markets specialty reactive inks that it believes have applications in the large educational and toy products market. Registrant also develops and markets technologies for document and product authentication which it believes can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. Registrant derives its revenues primarily from licensing its technologies on an exclusive or non-exclusive basis to licensees who incorporate the technologies into their product offering and from selling products incorporating its technologies to the licensees or to their licensed printers.


In the three years preceding 2014, Registrant experienced a period of decline in revenues resulting in significant operating losses and a decline in financial condition and a period of adverse liquidity that affected its business operations through mid-2014 when revenue increases generated from (1) higher license fees and royalties from two licensees in the entertainment and toy products market and (2) higher ink sales to the licensed printer of certain of the Company’s licensees in the entertainment and toy products market began to positively impact Registrant’s cash flow. This causes of the revenue decline and Registrant’s remedial actions are more fully described in Registrant’s Comprehensive Form 10-K for the three years ended December 31, 2012, 2013 and 2014 filed with the Securities and Exchange Commission on September 11, 2015. As a result of the aforementioned positive effects on its revenues during 2014, Registrant generated revenues of $922,800 in 2014, an increase of 18% compared to $750,200 in 2013. Registrant experienced further revenue growth in 2015 as revenues increased 3% in 2015 to $950,800. Registrant’s net loss in 2015 of $18,000 compared to net income of $7,900 in 2014 is attributable in part to (1) expenses incurred in filing the three year comprehensive Form 10-K in September 2015 and (2) accretion of interest related to the extension of the maturity dates of $95,000 of subordinated debentures. During 2015 Registrant concluded a new multi-year license with one of its two major licensees in the entertainment and toy products market and signed a multi-year license with an Australia-based company in the entertainment and toy products market.


Registrant continues its efforts to raise additional capital, in the form of debt, equity or both to support its working capital requirements and to provide funding for other business opportunities. There are no assurances that Registrant will be able to attract such additional capital.


There can be no assurances that the marketing and product development activities of the Company’s licensees will produce a significant increase in operating revenues for the Company, nor can the timing of any potential revenue increases be predicted.


Entertainment and Toy Technologies and Products


Registrant’s technology for the entertainment and toy products market consists of removable dyes that can be produced in a variety of colors and can be revealed by rubbing with a fingernail or other firm object such as a plastic pen cap. This technology, introduced in 2004, has been named Rub-it & Color. Registrant believes that this technology does not compromise the confidentiality of its security and authentication technologies whose chemistry is similar but the specific formulations are different for each application. Applications include children’s activity products such as coloring books without crayons or restaurant place mats, educational instruction books and testing review manuals. Registrant has obtained certifications of non-toxicity from the Consumer Products Services, Inc. and the American Society for Testing and Materials Laboratories.


Since January 2012, Registrant has had a license agreement, expiring in 2017, with a licensee who has a significant presence in the entertainment and toy products market which permits this licensee to exclusively market (1) a specific line of products incorporating Registrant’s technologies through a specific distribution channel but permitting Registrant to license the covered technologies to others (including Bendon, Inc., as noted below) for applications and sale through channels of distribution not available to this licensee under the terms of the license and (2) since January 2013, an additional technology on an exclusive basis in certain geographic areas of the world and on a non-exclusive basis in other geographic areas of the world. The licensee displayed products incorporating this additional technology to the marketplace at the American International Toy Fair in February 2015 and initial sales of products incorporating this technology were realized in the second quarter of 2015.




1



 


Registrant has a license agreement, expiring in 2019, containing guaranteed minimum royalties over the term of the license, with Bendon, Inc. (Bendon), an international, well-known children’s coloring and activity book publishing company that permits Bendon to exclusively market products with other characteristics that incorporate Registrant’s technologies through a distinctly different channel of distribution. The new four-year license agreement with Bendon was completed.in June 2015, replacing a previous three-year license agreement.


 These two licensees are well known and highly regarded participants in the entertainment and toy products market with significant market recognition and retail distribution. These two licensees have been distributing products incorporating Registrant’s technologies for more than three years. Since the inception of these licenses, sales of ink to the licensed printer of the licensees have been increasing. The agreements with both licensees contain renewal options but there can be no assurances that the licenses will continue in force at the same or more favorable terms beyond their current termination dates nor can there be any assurances that the relationships with these two licensees will generate significant additional operating revenues for Registrant in the future.


Since March 2011, Registrant has had a license agreement with a privately-held designer of creative educational products for children granting the licensee the exclusive right to utilize Registrant’s Rub-it & Color ink technology in a newly-created vertical market in the United States. In addition to an annual license fee, Registrant receives a royalty based on units of product produced. The license was renewed in July 2014 for a period of up to three years. There can be no assurances that the marketing efforts of Registrant’s licensee will generate significant additional operating revenues for the Registrant in the future.


Since November 2012, Registrant has had a license agreement with a privately-held children’s meal entertainment program provider that allows the licensee to use Registrant’s Rub-it & Color ink technology in children’s menus, placemats, butcher paper and certain other products for restaurant use and for sale in certain children’s retail outlets. In December 2014, the license was renewed for a period of six years, expiring in December 2020. There can be no assurances that the marketing efforts of Registrant’s licensee will generate significant additional operating revenues for the Registrant in the future.  


 Since April 2013, Registrant has had a license with a nationally known distributor of seasonal boxed greeting cards and other products which permits the licensee to market certain products distributed by the licensee that incorporate specific technologies of the Registrant. Unless renewed, the license terminates in December 2016. The licensee introduced products incorporating Registrant’s technologies in late 2014. Revenues were realized by Registrant in both 2014 and 2015. There can be no assurances that the marketing efforts of Registrant’s licensee will generate significant additional operating revenues for the Registrant in the future.


In October 2015, Registrant negotiated a multi-year license containing guaranteed minimum royalties with a privately-held international publisher of family products and publications based in Australia. Unless renewed, the license terminates in December 2018. The license allows the licensee to market certain products that incorporate specific technologies of the Registrant on an exclusive basis in certain specific countries and on a non-exclusive basis in other countries with the exclusion of the United States, Canada and Mexico. The license agreement contains a renewal option but there can be no assurances that the license will continue in force at the same or more favorable terms beyond its current termination date nor can there be any assurances that the relationship with this new licensee will generate significant additional operating revenues for the Registrant in the future.


Registrant continues to pursue additional licensing opportunities for its technologies in the large worldwide entertainment and toy products market through direct marketing efforts and attendance at trade shows. During 2015, Registrant derived approximately 80% of its 2015 total revenues from its licensees and their licensed printers in the entertainment and toy products market compared to approximately 76% derived from this market in 2014. There can be no assurances that the Registrant’s available resources, even with additional investment, if obtained, for marketing and further technical development of this product line will be sufficient to increase Registrant’s revenues.


Anti-Counterfeiting and Anti-Diversion Technologies and Products


Continuing developments in copying and printing technologies have made it ever easier to counterfeit a wide variety of documents. Product labels and packaging, retail receipts, event and transportation tickets and the like are all susceptible to counterfeiting, and Registrant believes that losses from such counterfeiting have increased substantially with improvements in the copying and printing technologies. Product counterfeiting has long caused losses to manufacturers of brand name products, and Registrant believes these losses have increased as the counterfeiting of labeling and packaging has become easier.




2



 


Registrant's proprietary document authentication technologies are useful to businesses desiring to authenticate a wide variety of printed materials and products. One product incorporating these technologies has the ability to print invisibly on certain areas of a document. When authentication of certain documents is required, the invisible printing can be activated or revealed by use of a special highlighter pen. This technology is marketed under the trademark COPIMARK. Other variations of the COPIMARK technology involve multiple color responses from a common pen, visible marks of one color that turn another color with the pen or visible and invisible marks that turn into a multicolored image. A related technology is Nocopi's RUB & REVEAL system, which permits the invisible printing of an authenticating symbol or code that can be revealed by rubbing a fingernail over the printed area. These technologies provide users with the ability to authenticate documents and detect counterfeit documents. Applications include the authentication of documents having intrinsic value, such as merchandise receipts, checks, travelers' checks, gift certificates and event tickets, and the authentication of product labeling and packaging. When applied to product labels and packaging such technologies allow detection of counterfeit products, the labels and packaging of which would not contain the authenticating marks invisibly printed on the packaging or labels of the legitimate product. Registrant has focused recent marketing efforts on specific industries it believes may be affected by product counterfeiting. These technologies also combat product diversion (i.e. sale of legitimate products through unauthorized distribution channels or in unauthorized markets). A related technology of Registrant, the invisible inkjet technology permits manufacturers and distributors to track the movement of products from production to ultimate consumption when coupled with proprietary software. Management believes that the “track and trace” capability provided by this technology can be attractive to brand owners and marketers. There are no assurances that its ongoing initiatives will result in additional revenues in the future.


Registrant currently participates in the retail receipt and document fraud market through licensing arrangements with seven printers and distributors in the United States and Canada who provide loss prevention products to retailers and other outlets. Registrant believes that these technologies are most efficiently marketed through the use of licensed printers and distributors. Registrant continues to use its available internal sales and technical resources to expand the number of licensees marketing its technologies in this market. During 2015, Registrant derived approximately 10% of its 2015 total revenues from its licensees in the retail loss prevention market compared to approximately 13% derived from this market in 2014. There can be no assurances that Registrant’s strategy for the retail loss prevention market will result in significant additional revenues and cash flow for Registrant.


The following table illustrates the approximate percentage of Registrant's revenues accounted for by each type of its products for each of the two last fiscal years:


 

 

 

 

 

Year Ended December 31,

 

Product Type

 

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

Entertainment and Toy Technologies and Products

 

 

 

 

 

 

80

%

 

 

76

%

Anti-Counterfeiting and Anti-Diversion Technologies and Products

 

 

 

 

 

 

20

%

 

 

24

%


Marketing


Registrant’s marketing approach focuses on the sufficient flexibility in its products and technologies and its ability to provide innovative, cost effective technologies for the entertainment and toy products market as well as solutions to a wide variety of counterfeiting, diversion and copier fraud problems. As a technology company, Registrant generates revenues primarily by collecting license fees and royalties from market-specific businesses that incorporate Registrant's technologies into their products and, in certain cases, sales of Registrant’s inks to these licensees and their designated manufacturers. Registrant also licenses its technologies directly to end-users.


Registrant has identified two major markets for its technologies and products, the entertainment and toy product market and the anti-counterfeiting/anti-diversion market. Registrant’s adverse financial condition in the years from 2011 to the present has limited its sales efforts to direct selling by Registrant’s personnel. Sales travel, attendance at trade shows and marketing expenditures have been constrained. Current marketing efforts are focused on Registrant’s developed technologies that can be utilized in geographic or market areas not contractually committed to an existing licensee on an exclusive basis. There can be no assurances that the limited resources Registrant can dedicate to its marketing activities will result in significant additional revenues in the future.


Registrant presently markets its technologies through its own employees. In Europe, certain of its security technologies are marketed by Contrast Technologies, formerly known as Euro-Nocopi, S.A., and a former affiliate of the Registrant, which holds certain European marketing rights with respect to those technologies.




3



 


Major Customers


During 2015, Registrant made sales or obtained revenues equal to 10% or more of Registrant's 2015 total revenues from two non-affiliated customers who individually accounted for approximately 53% and 17%, respectively, of 2015 revenues of the Company. During 2014, Registrant made sales or obtained revenues equal to 10% or more of Registrant's 2014 total revenues from two non-affiliated customers who individually accounted for approximately 47% and 19%, respectively, of 2014 revenues of the Company.


Manufacturing


Registrant has a small facility for the manufacture of its security inks. Except for this facility, Registrant does not maintain manufacturing facilities. Registrant presently subcontracts the manufacture of its applications (mainly printing and coating) to third party manufacturers and expects to continue such subcontracting. Because some of the processes that Nocopi uses in its applications are based on relatively common manufacturing technologies, there appears to be no technical or economic reason for Registrant to invest capital in its own manufacturing facilities.  


Registrant has established a quality control program that currently entails laboratory analysis of developed technologies. When warranted, Registrant’s specially trained technicians travel to third party production facilities to install equipment, train client staff and monitor the manufacturing process.


Patents


Since its inception, Registrant has received various patents in the United States, Canada, South Africa, Saudi Arabia, Australia, New Zealand, Japan, France, the United Kingdom, Belgium, the Netherlands, Germany, Austria, Italy, Sweden, Switzerland, Luxembourg, and Liechtenstein. Registrant currently has obtained patent protection on substantially all of its security inks including the RUB & REVEAL system and the Rub-it & Color technology. Registrant’s latest patent is on a certain newly developed technology that Registrant believes has applications in the entertainment and toy products market.


When a new product or process is developed, the developer may seek to preserve for itself the economic benefit of the product or process by applying for a patent in each jurisdiction in which the product or process is likely to be exploited. Generally speaking, in order for a patent to be granted, the product or process must be new and be inventively different from what has been previously patented or otherwise known anywhere in the world. Patents generally have a duration of twenty years from the date of application depending on the jurisdiction concerned, after which time any person is free to exploit the product or process covered by a patent. A person who is the owner of a patent has, within the jurisdiction in which the patent is granted, the exclusive right, either directly or through licensees, to prevent any person from infringing on the patent.


The granting of a patent does not prevent a third party from seeking a judicial determination that the patent is invalid. Such challenges to the validity of a patent are not uncommon and are occasionally successful. There can be no assurance that a challenge will not be filed to one or more of Registrant's patents and that, if filed, such challenge(s) will not be successful.


In the United States and some other countries, patent applications are automatically published at a specified time after filing. Nocopi is required to pay annuities from time to time on patents to keep them in force; with this in mind, Nocopi makes an annual evaluation of its patents in order to determine which patents it will continue to maintain. In Europe, the territory of Contrast Technologies, formerly known as Euro-Nocopi, S.A. (“Contrast”), annuities for European patents are paid by Contrast.


Research and Development


Registrant has been involved in research and development since its inception. Although Registrant’s financial condition has forced it to limit funding for research and development in recent years, it intends to continue its research and development activities in three areas, to the extent feasible. First, Registrant will seek to continue to refine its present family of products. Second, Registrant will seek to develop specific customer applications. Finally, Registrant will seek to expand its technology into new areas of implementation. There can be no assurances that Registrant will continue to have funds available to maintain its research and development activities at current or increased levels.


During the years ended December 31, 2015, and December 31, 2014, Registrant expended approximately $128,100 and $121,600, respectively, on research and development.




4



 


Competition


In the area of document and product authentication and serialization, Registrant is aware of other covert and overt surface marking technologies requiring decoding implements or analytical methods to reveal certain information. These technologies are offered by other companies for the same anti-counterfeiting and anti-diversion purposes for which the Registrant markets its covert technologies. These include, among others, biological DNA codes, microtaggants, thermochromic, UV and infrared inks as well as encryption, 2D symbology and laser engraving.  Nonetheless, Registrant believes its patented and proprietary technologies provide a unique and cost-effective solution to the problem of counterfeiting and gray marketing in the document and product authentication markets it has traditionally sought to exploit.


The entertainment and toy products markets include numerous potential competitors who have significantly greater financial resources and presence in these markets than Registrant.


The loss prevention market includes numerous potential competitors, including large-publicly traded companies such as NCR Corporation and regional paper converters, many of whom have greater financial resources and presence in these markets than Registrant.


Registrant currently has limited resources and competes with businesses that have greater financial resources than Registrant. There can be no assurance that businesses with greater resources than Registrant will not enter Registrant’s markets and compete successfully with Registrant.


Contrast Technologies (formerly Euro-Nocopi, S.A.)


Contrast Technologies, formerly known as Euro-Nocopi, S.A., is a former affiliate of Registrant which, since June 2003, has held a perpetual royalty-free license to exploit certain of Registrant’s technologies in Europe.


Employees


At March 15, 2016 and December 31, 2015, Registrant had three full-time and two part-time employees.


Financial Information about Foreign and Domestic Operations


Registrant conducts its operations solely in the United States; however, it does have licensees and customers in Asia and Australia. These licensees and customers accounted for approximately 54% of Registrant’s gross revenues in 2015 and approximately 48% in 2014. Certain information concerning Registrant's foreign and domestic operations is contained in Note 14 to Registrant's Financial Statements included elsewhere in this Annual Report on Form 10-K.


ITEM 1A. RISK FACTORS


Not required for a smaller reporting company.


ITEM 1B. UNRESOLVED STAFF COMMENTS


None.


ITEM 2. PROPERTIES


Registrant's corporate headquarters, research and ink production facilities are located at 480 Shoemaker Road, Suite 104, King of Prussia, Pennsylvania 19406. Its telephone number is (610) 834-9600. These premises consist of approximately 6,100 square feet of space in a multi-tenant building leased by the Registrant from an unaffiliated third party pursuant to a lease that commenced in January 2014 and expires in April 2019. Current monthly rent under this lease is $3,778; this amount escalates an amount of approximately three percent each year. In addition to rent, Registrant is responsible for its pro-rata share of the operating costs of the building. Registrant incurred leasehold improvement expenditures of approximately $19,700 through March 15, 2016. Registrant believes that additional leasehold improvement expenditures will not be significant. Registrant believes that this space will be adequate for its current needs and that additional space will be available as needed.




5



 


ITEM 3. LEGAL PROCEEDINGS


Registrant is not aware of any pending litigation (other than ordinary routine litigation incidental to its business where, in management's view, the amount involved is not material) to which Registrant is or may be a party, or to which any of its properties is or may be subject, nor is it aware of any pending or contemplated proceedings against it by any governmental authority. Registrant knows of no material legal proceedings pending or threatened, or judgments entered against, any director or officer of Registrant in his capacity as such.


ITEM 4. MINE SAFETY DISCLOSURES


Not applicable.



6



 


PART II


ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES


Registrant's Common Stock is currently traded on the OTC Pink tier of the over-the-counter (“OTC”) market under the symbol "NNUP". Investors can find Real-Time quotes and market information on the Company on www.otcmarkets.com. The table below presents the range of high and low sales prices of Registrant's Common Stock by calendar quarter for the last two full fiscal years and for a recent date, as reported by OTC Markets Group Inc.


 

 

High

 

 

Low

 

 

 

 

 

 

 

 

January 1, 2014 to March 31, 2014

 

$.150

 

 

$.012

 

April 1, 2014 to June 30, 2014

 

$.020

 

 

$.012

 

July 1, 2014 to September 30, 2014

 

$.021

 

 

$.012

 

October 1, 2014 to December 31, 2014

 

$.013

 

 

$.006

 

 

 

 

 

 

 

 

 

 

January 1, 2015 to March 31, 2015

 

$.047

 

 

$.006

 

April 1, 2015 to June 30, 2015

 

$.025

 

 

$.009

 

July 1, 2015 to September 30, 2015

 

$.021

 

 

$.006

 

October 1, 2015 to December 31, 2015

 

$.039

 

 

$.004

 

 

 

 

 

 

 

 

 

 

January 1, 2016 to March 15, 2016

 

$.078

 

 

$.006

 


As of March 15, 2016, 58,599,016 shares of Registrant's Common Stock were outstanding. The number of holders of record of Registrant's Common Stock was approximately 600. However, Registrant estimates that it has a significantly greater number of common stockholders because a number of shares of Registrant's Common Stock are held of record by broker-dealers for their customers in street name. In addition to the 58,599,016 shares of Common Stock which are outstanding, Registrant, at March 15, 2016, has reserved for the issuance of approximately 5,832,000 shares of its Common Stock which underlie warrants to purchase Common Stock of the Registrant and the conversion of convertible debentures and interest into Common Stock of the Registrant.


The Company did not pay dividends in 2015 or 2014 and does not anticipate paying any such dividends in the foreseeable future. Any determination to pay dividends in the future will be at the discretion of the Company’s Board of Directors and will be dependent upon the Company’s results of operations, financial condition, contractual restrictions and other factors deemed relevant by the Board of Directors.


Information required with respect to Equity Compensation Plans in this Item 5 is included in Item 12 on page 20 of this report on Form 10-K.


Recent Sales of Unregistered Securities


On July 8, 2014, the Company issued a convertible debenture for $22,940 to Henry C. Friedman, brother-in-law of Michael A. Feinstein, the Company’s Chairman of the Board, which included warrants to purchase 114,700 shares of the Company’s Common Stock at $0.02 per share. The warrant is exercisable two years after issuance and expires seven years after issuance. The debenture is due in two years. At the option of the lender, the debenture and accrued interest is convertible in whole or part into Common Stock of the Company at $0.05 per share. The convertible debenture was issued in exchange for a $20,000 short-term loan along with accrued interest in a transaction approved by the disinterested members of the Company’s Board of Directors.


On July 8, 2014, the Company issued a convertible debenture for $5,333 to Herman M. Gerwitz, a Director, which included warrants to purchase 26,665 shares of the Company’s Common Stock at $0.02 per share. The warrant is exercisable two years after issuance and expires seven years after issuance. The debenture is due in two years. At the option of the lender, the debenture and accrued interest is convertible in whole or part into Common Stock of the Company at $0.05 per share. The convertible debenture was issued in exchange for a $4,500 short-term loan along with accrued interest in a transaction approved by the disinterested members of the Company’s Board of Directors.




7



 


On July 22, 2014, the Company issued a convertible debenture for $5,000 to an individual accredited investor, which included warrants to purchase 25,000 shares of the Company’s Common Stock at $0.02 per share. The warrant is exercisable two years after issuance and expires seven years after issuance. The debenture is due in two years. At the option of the lender, the debenture and accrued interest is convertible in whole or part into Common Stock of the Company at $0.05 per share.


The recipients of securities in these transactions had adequate access, through employment or business relationships, to information about the Company. No underwriters were involved in these transactions or received any commissions or other compensation. Proceeds of the sales of the convertible debentures were used to fund the Company’s working capital requirements.


In July 2015, the common stock private placement was extended to December 31, 2016 by the Company’s Board of Directors.


Issuer Repurchases of Equity Securities


None.


ITEM 6. SELECTED FINANCIAL DATA


Not required for a smaller reporting company.


ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


Forward-Looking Information


This Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, regarding, among other things, anticipated improvements in operations, the Company’s plans, earnings, cash flow and expense estimates, strategies and prospects, both business and financial. All statements other than statements of current or historical fact contained in this report are forward-looking statements. The words “believe,’’ “expect,’’ “anticipate,’’ “should,’’ “plan,’’ “will,’’ “may,’’ “intend,’’ “estimate,’’ “potential,’’ “continue’’ and similar expressions, as they relate to the Company, are intended, where possible, to identify forward-looking statements.


The Company has based these forward-looking statements largely on its current expectations and projections about future events, financial trends, market opportunities, competition, and the adequacy of the Company’s available cash resources, which the Company believes may affect its financial condition, results of operations, business strategy and financial needs. This Form 10-K also contains forward-looking statements attributed to third parties. All such statements can be affected by inaccurate assumptions, including, without limitation, with respect to risks, uncertainties, anticipated operating efficiencies, new business prospects and the rate of expense increases. In light of these risks, uncertainties and assumptions, the forward-looking statements in this report may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. For these reasons, and because of the uncertainty relating to the current financial conditions in today’s economic environment and the potential reduction in demand for the Company’s products, you should not consider this information to be a guarantee by the Company or any other person that its objectives and plans will be achieved. When you consider these forward-looking statements, you should keep in mind the “Risk Factors” and other cautionary statements set forth in this Item 7 and elsewhere in this Form 10-K. The Company’s forward-looking statements speak only as of the date made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and related notes, and keeping in mind this cautionary statement regarding forward-looking information.




8



 


Results of Operations


The Company’s revenues are derived from royalties paid by licensees of the Company’s technologies, fees for the provision of technical services to licensees and from the direct sale of (i) products incorporating the Company’s technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of the Company’s technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by the Company’s licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.


The Company recognizes revenue on its lines of business as follows:


a) License fees and royalties are recognized when the license term begins. Upon inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process, which generally is ratably over the license term;


b) Product sales are recognized upon shipment of products, when the price is fixed or determinable and collectability is reasonably assured; and


c) Fees for technical services are recognized when (i) the service has been rendered; (ii) an arrangement exists; (iii) the price is fixed or determinable based upon a per diem or hourly rate; and (iv) collectability is reasonably assured.  


The Company believes that, as fixed cost reductions beyond those it has achieved in recent years may not be achievable, its operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.


Both the absolute amount of the Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. The Company has a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on the Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when the Company agrees to revise such terms, revenues from the customer may be affected.


Comparison of the Years ended December 31, 2015 and 2014


Revenues for 2015 were $950,800, an increase of approximately 3%, or $28,000, from $922,800 in 2014. Licenses, royalties and fees decreased in 2015 by approximately 6%, or $20,100, to $338,700 from $358,800 in 2014. The decrease in licenses, royalties and fees is due primarily to lower licensing revenues from two existing licensees in the entertainment and toy products market, one of whom signed a new four-year license in the second quarter of 2015 and lower consulting revenue related to the expiration in 2014 of a consulting arrangement with a customer offset in part by higher licensing fees from two licensees in the entertainment and toy products market and initial licensing fees from a new licensee in the fourth quarter of 2015. Product and other sales increased by $48,100, or approximately 9%, to $612,100 in 2015 from $564,000 in 2014. The higher level of ink sales in 2015 compared to 2014 is due primarily to higher ink requirements of the licensed third party printers used by the Company’s licensees in the entertainment and toy products market. Sales of ink to the licensed printers of its licensees in the entertainment and toy products market were approximately $73,800 higher in 2015 compared to 2014. Sales of security ink to the Company’s licensees in the retail receipt and document fraud market decreased by approximately $27,700 in 2015 compared to 2014. The Company derived $757,300, or approximately 80% of total revenues, from licensees and their licensed printers in the entertainment and toy products market in 2015 compared to $699,400, or approximately 76% of total revenues, in 2014. The Company’s licensees in the entertainment and toy products market continue to develop new products for this market and improve their current offerings; however, their sales will be affected by marketplace reaction to the new and improved products, economic conditions that influence this market segment and the economy as a whole. Revenues that the Company derives from these licensees will be similarly affected. There can be no assurances that the marketing and product development activities of licensees in the entertainment and toy products market will produce increased revenues for the Company in future periods, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions currently being experienced worldwide.




9



 


Gross profit increased to $617,800, or approximately 65% of revenues, in 2015 from $598,500, or approximately 65% of revenues, in 2014. Licenses, royalties and fees have historically carried a higher gross profit than product sales, which generally consist of supplies or other manufactured products that incorporate the Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by the Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees. The higher gross profit in 2015 compared to 2014 reflects higher product sales along with a favorable mix of product sales offset in part by lower licenses, royalties and fees.


As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both gross profit from licenses, royalties and fees as well as overall gross profit. Due primarily to the lower revenues in 2015 compared to 2014, the gross profit from licenses, royalties and fees decreased to approximately 77% of revenues from licenses, royalties and fees in 2015 from approximately 79% in 2014.


Gross profit, expressed as a percentage of revenues, of product and other sales is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. As a result of both increased ink sales and favorable product mix, the gross profit from product and other sales increased to approximately 58% of revenues in 2015 compared to approximately 56% of revenues from product and other sales in 2014.


Research and development expenses were $128,100 in 2015 compared to $121,600 in 2014. The increase in 2015 compared to 2014 resulted primarily from higher employee salary and benefit expenses in 2015 compared to 2014.


Sales and marketing expenses of $202,800 in 2015 compared to $194,500 in 2014. The increase in 2015 compared to 2014 resulted primarily from higher commission expense in 2015 compared to 2014 resulting from a higher level of revenues in 2015 compared to 2014 and higher benefit expenses in 2015 compared to 2014.


General and administrative expenses increased to $325,600 in 2015 from $253,400 in 2014. The increase in 2015 compared 2014 is due primarily to higher expenses incurred in 2015 compared to 2014 related to the Company’s filing of the comprehensive annual report on Form 10-K and the first and second quarter 2015 Form 10-Q’s that were filed during the third quarter of 2015. These expenses included legal and audit fees incurred in 2015 as well as expenses related to the electronic filing of the documents.


Other income (expenses) includes, in 2015, the reversal of approximately $56,300 of accounts payable related to invoices received from 2001 through 2009 from a professional services business that provided legal services to the Company and an individual that provided consulting services to the Company in 2009 that the Company, with legal counsel, has determined to be no longer statutorily payable as the statute of limitations to bring claims has expired. Additionally, other income (expenses) includes interest on unsecured loans from five individuals, on convertible debentures held by ten investors and, in 2014, on funds borrowed under the Company’s promissory note with a bank. Also included in other income (expenses) is accretion of debt discounts related to the issuance of convertible debentures totaling $128,400 and, in 2015, the extension of the maturity dates of $95,000 of convertible debentures.


The net loss of $18,000 in 2015 compared to net income of $7,700 in 2014 resulted primarily from a higher gross profit on a higher level of revenues in 2015 compared to 2014 offset by higher overhead expenses in 2015 compared 2014 along with higher accretion of interest in 2015 compared to 2014.


Management of the Company does not believe that inflation and changing prices have had a significant effect on its revenues and results of operations during the years ended December 31, 2015 and 2014.


Plan of Operation, Liquidity and Capital Resources


The Company’s cash decreased to $11,400 at December 31, 2015 from $28,000 at December 31, 2014. During 2015, the Company generated $41,800 from its operating activities, used $8,900 for capital equipment, repaid $10,000 to a convertible debenture holder and repaid $39,500 to two individual lenders.




10



 


During 2015, the Company’s revenues increased primarily as a result of higher sales of ink to the authorized printer of four of the Company’s licensees in the entertainment and toy products market and higher license fees from two licensees, one of whom is in the entertainment and toy products market. The Company’s total overhead expenses increased 2015 compared 2014. As a result of these factors, the Company experienced a net loss of $18,000 in 2015. The Company had positive operating cash flow of $41,800 in 2015. At December 31, 2015, the Company had negative working capital of $364,000 and a stockholders’ deficiency of $438,100. For the full year of 2014, the Company had net income of $7,700 and had positive operating cash flow of $14,500. At December 31, 2014, the Company had negative working capital of $424,500 and a $438,200 stockholders’ deficiency.


From January 1, 2014 to December 31, 2015, the Company repaid $44,500 of $92,500 of short-term loans that had been outstanding at January 1, 2014 and converted $24,500 of these short-term loans into convertible debentures maturing in 2016. In 2015, the Company repaid $10,000 of convertible debentures and extended the maturity dates of $95,000 of convertible debentures from 2015 to 2017. In 2014, the Company repaid the remaining balance of a $100,000 promissory note with a bank. Borrowings and sales of common stock in recent years have allowed the Company to remain in operation through the current date. There can be no assurances that the Company will be able to secure sufficient additional funding through investments or borrowings that will allow the Company to fund losses that it presently believes may continue during 2016. The Company believes that without additional investment, it may be forced to cease operations at an undetermined date in the future. Information regarding the Company’s financing activities in periods prior to this Annual Report on Form 10-K is included in prior filings including the Company’s Comprehensive Annual Report on Form 10-K for the Years ended December 31, 2012, 2013 and 2014 filed with the Securities and Exchange Commission on September 11, 2015.


In July 2015, the common stock private placement was extended to December 31, 2016 by the Company’s Board of Directors.


Management of the Company believes that it may need to obtain additional capital in the future to support the working capital requirements associated with its existing revenue base and to fund potential operating losses that it believes may occur as the state of the worldwide economy remains uncertain. There can be no assurances that the Company will be successful in obtaining sufficient additional capital, or if it does, that the additional capital will enable the Company operate profitably in the future and develop new revenue sources to have a material positive effect on the Company’s operations and cash flow. The Company believes that without additional investment, it may be forced to cease operations at an undetermined time in the future.


There can be no assurances that the Company will be successful in obtaining additional investment. There can be no assurances that revenues in future periods will be sustained at levels that will allow it to achieve and maintain positive cash flow.


The Company continues to maintain a cost containment program including curtailment, where possible, of discretionary research and development and sales and marketing expenses.


The Company’s plan of operation for the twelve months beginning with the date of this annual report consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships the Company has developed in the entertainment and toy products market including two licensees with a significant presence in the entertainment and toy products market that have been marketing products incorporating the Company’s technologies since 2012. These two licensees in the entertainment and toy products market are well known and highly regarded participants in this market. The Company believes that these two licensees will expand their offerings incorporating the Company’s technologies currently being marketed and will introduce new products incorporating available technologies covered by the license agreements that are not currently being marketed by them. The Company plans to continue developing applications for these licensees while expanding its licensee base in the entertainment and toy market. The Company has additional licensees marketing or developing products incorporating the Company’s technologies in certain geographic and niche markets of the overall entertainment and toy products market. The Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. The Company will continue to adjust its production and technical staff as necessary. The Company will also, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond its current capacity. Additionally, the Company will pursue opportunities to market its current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable the Company to generate additional revenues and positive cash flow.




11



 


The Company has received and continues to seek additional capital, in the form of debt, equity or both, to support its working capital requirements. There can be no assurances that the Company will be successful in raising additional capital, or that such additional capital, if obtained, will enable the Company to generate additional revenues and positive cash flow.


The Company generates a significant portion of its total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. During the year, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment. As a result, the Company’s revenues, results of operations and liquidity may be negatively impacted as they were in previous years.


Risk Factors


The Company’s operating results, financial condition and stock price are subject to certain risks, some of which are beyond its control. These risks could cause the Company’s actual operating and financial results to differ materially from those expressed in its forward looking statements, including the risks described below and the risks identified in other documents which are filed and furnished with the SEC:


Limited Interim Historical Information. The Company filed a comprehensive annual report on Form 10-K for the fiscal years ended December 31, 2012, 2013 and 2014 on September 11, 2015. The Form 10-K contained summarized quarterly financial information for each of the quarters ended June 30 and September 30, 2012 and for each of the quarters ended March 31, June 30 and September 30, 2013 and 2014. As the complete periodic filings for those periods have not been filed, certain financial information, disclosures and discussions normally contained in a Form 10-Q were not included in the Form 10-K. The omission of the information that would have been contained in these periodic filings leaves current and prospective investors, customers, employees and others without this source of information about the Company’s business achievements and prospects and may negatively impact the Company’s business opportunities and its ability to raise capital. There can be no assurances that the Company will be able to remain current with its required SEC filing obligations in the future.   


Access to Capital. The Company anticipates that it may need to raise capital in the future to fund its historical and new business operations. Negative or uncertain global economic conditions could make it more difficult for the Company to raise capital. If the Company is unable to secure capital, if needed, in the future, in the form of debt, equity or both, it may be forced to cease operations. There can be no assurances that, if required, the Company will be successful in obtaining additional investment in sufficient amounts to fund its ongoing business operations.


Dependency on Major Customers. The Company is dependent on its licensees to develop new products and markets that will generate increases in its licensing and product revenues. The inability of the Company’s licensees to maintain at least current levels of sales of products utilizing the Company’s technologies could adversely affect the Company’s operating results and cash flow. To the extent that the Company’s licensees are adversely affected by negative economic conditions, the Company’s revenues may also be negatively impacted. The Company has derived a significant percentage of its revenues through licensing relationships with two major customers. Revenues obtained directly from these customers and indirectly, through the customers’ third party licensed printer, equaled approximately 73% of the Company’s revenues in 2015. The Company also has, from time to time, substantial receivables from these businesses. The Company has a license agreement containing guaranteed minimum royalties expiring in 2019 with one of these two licensees and a license agreement with the second that expires in 2017. Products incorporating the Company’s technologies that are sold by these two licensees have certain dissimilar characteristics and are marketed generally through distinctly different channels of distribution. These two licensees are well known and highly regarded participants in the entertainment and toy products market. The agreements with both licensees contain renewal options but there can be no assurances that the licenses will continue in force at the same or more favorable terms beyond their current termination dates, nor can there be any assurances that the relationships with these two new licensees will generate increased revenues for the Company in the future.


Possible Inability to Develop New Business. While the Company raised cash through additional capital investment, sales of convertible debentures and loans from individuals in 2012, 2013 and 2014, it limited increases in its operating expenses, reduced its operating expenses when possible and deferred payment of certain obligations to employees and service providers. Management of the Company believes that any significant improvement in the Company’s cash flow must result from increases in revenues from traditional sources and from new revenue sources. The Company’s ability to develop new revenues may depend on the extent of both its marketing activities and its research and development activities, both of which are limited. There are no assurances that the resources that the Company can devote to marketing and to research and development will be sufficient to increase its revenues to levels that will enable it to return to and maintain positive operating cash flow in the future.




12



 


Inability to Obtain Raw Materials and Products for Resale. The Company’s adverse financial condition has required it from time to time to significantly defer payments due to (i) vendors who supply raw materials and other components of its security inks, (ii) providers of professional and other services and (iii) certain employees to whom salary and sales commissions are owed. As a result, the Company is required to pay cash in advance of shipment to certain of its suppliers. The inability to obtain materials on a timely basis and the possibility that certain vendors may permanently discontinue supplying the Company with needed products and services may result in delayed shipments to customers and further impact the Company’s ability to service its customers, thereby adversely affecting the Company’s relationships with its customers and licensees. There can be no assurances that the Company will be able to maintain its vendor relationships in an acceptable manner.


Uneven Pattern of Quarterly and Annual Operating Results. The Company’s revenues, which are derived primarily from licensing and sales of products incorporating its technologies as well as royalties from these products, are difficult to forecast; such forecasting difficulty is due to, among other reasons, the long sales cycle of the Company’s technologies, the potential for customer delay or deferral of implementation of the Company’s technologies, the size and timing of inception of individual license agreements, the success of the Company’s licensees and strategic partners in exploiting the market for the licensed products, modifications of customer budgets, and uneven patterns of royalty revenue and product orders. As the Company’s revenue base is not substantial, delays in the finalization of license contracts, the implementation of the technology to initiate the revenue stream and the ordering decisions of customers can have a material adverse effect on the Company’s quarterly and annual revenue expectations. As the Company’s operating expenses are substantially fixed, income expectations will be subject to a similar adverse outcome. As licensees for the entertainment and toy products markets are added, the predictability of the Company’s revenue stream may be further impacted.


Volatility of Stock Price. The market price for the Company’s common stock has historically experienced significant fluctuations and may continue to do so. With the exception of 2007, 2013 and 2014 from its inception, the Company has operated at a loss and has not produced revenue levels traditionally associated with publicly-traded companies. The Company’s common stock is not listed on a national or regional securities exchange and, consequently, the Company receives limited publicity regarding its business achievements and prospects. Additionally, securities analysts and traders do not extensively follow the Company’s stock and its stock is thinly traded. The Company’s market price may be affected by announcements of new relationships or modifications to existing relationships. The stock prices of many developing public companies, particularly those with small capitalizations, have experienced wide fluctuations not necessarily related to operating performance. Such fluctuations may adversely affect the market price of the Company’s common stock.


Intellectual Property. The Company relies on a combination of protections as may be available under applicable domestic, foreign or international patent, trademark and trade secret laws. The Company also relies on confidentiality, non-analysis and licensing agreements to establish and protect its rights in its proprietary technologies. While the Company attempts to protect these rights, its technologies may be compromised through reverse engineering, independent invention or other means. In addition, the Company’s ability to enforce its intellectual property rights through appropriate legal action has been and will continue to be limited by its adverse liquidity. There can be no assurances that the Company will be able to protect the basis of its technologies from discovery by third parties or to preclude third parties from conducting activities that infringe on the Company’s rights. The Company’s adverse liquidity situation also impacts its ability to obtain patent protection on its intellectual property and to maintain protection on previously issued patents. There can be no assurances that the Company will be able to continue to prosecute new patents and maintain issued patents. As a result, the Company’s customer and licensee relationships could be adversely affected, and the value of the Company’s technologies and intellectual property (including their value upon liquidation) could be substantially diminished.


Economic Conditions. The Company’s revenue is susceptible to changes in general economic conditions. The Company’s sales, liquidity and overall results of operations may be negatively affected by decreasing consumer confidence, slowdowns in consumer spending or other downturns in the U.S. economy as a whole or in any geographic markets from which the Company derives revenue. In addition, these factors may result in decreased customer and licensee demand for the Company’s products and may negatively impact the Company’s ability to develop new customers and licensees. Due to uncertainties surrounding the worldwide economy, the Company is unable to predict the effect of such conditions on its customers and licensees. Consequently, the Company cannot predict the scope or magnitude of the negative effect resulting from ongoing global financial uncertainties or economic slowdowns.


Recently Adopted Accounting Pronouncements


As of December 31, 2015 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.




13



 


Recently Issued Accounting Pronouncements Not Yet Adopted


In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments in this Update provide guidance about management’s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued and to provide related footnote disclosures. Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management is assessing the impact of the adoption to the financial statements.


Off-Balance Sheet Arrangements


The Company does not have any off-balance sheet arrangements.


ITEM 7A. QUANTITIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Not required for a smaller reporting company.


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA


For information required with respect to this Item 8, see index to Financial Statements and Schedules on page F-1 of this report on Form 10-K.


ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE


Not applicable.


ITEM 9A. CONTROLS AND PROCEDURES


Disclosure Controls and Procedures


The Company’s disclosure controls and procedures are designed to provide reasonable assurance that material information required to be included in its periodic SEC reports is recorded, processed, summarized and reported within the time periods specified in the relevant SEC rules and forms. The Company has carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded, as of the end of the period covered by this report, that the Company’s disclosure controls and procedures are effective.


Internal Control over Financial Reporting


Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with U.S. GAAP. Internal control over financial reporting includes maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, that receipts and expenditures of the Company are being made only with management authorization and provide reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on the Company’s financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements in the Company’s financial statements on a timely basis.




14



 


Management assessed the effectiveness of the Company’s internal control over financial reporting based on the Committee of Sponsoring Organizations of the Treadway Commission in “Internal Control-Integrated Framework (1992).” Based on this assessment, management believes that, as of December 31, 2015, the Company’s internal control over financial reporting was effective.


This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. The attestation report requirement for non-accelerated filers was permanently removed from the Sarbanes-Oxley Act by Section 989C of the Dodd-Frank Act as adopted by the SEC.


Changes in Internal Control over Financial Reporting


There have been no changes in the Company’s internal controls over financial reporting during the fourth quarter of 2015 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.


ITEM 9B. OTHER INFORMATION


None.




15



 


PART III


ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE


The directors, officers and named executive of the Company, their ages, present positions with the Company, and a summary of their business experience are set forth below.


Michael A. Feinstein, M.D., 69, Chairman of the Board of Directors since December 1999 and Nocopi’s Chief Executive Officer since February 2000, has been a practicing physician in Philadelphia for more than thirty years, serving for more than twenty-five years as the President of a group medical practice which includes three physicians. He is a Fellow of the American College of Obstetrics and Gynecology and of the American Board of Obstetrics and Gynecology. He received his B.A. from LaSalle University and his M.D. from Jefferson Medical College. He has represented Nocopi in numerous licensing negotiations, governmental meetings and capital raises. The Board of Directors believes that Dr. Feinstein’s considerable personal experience as a business owner and investor in publicly traded businesses makes him well suited to serve as a member of Nocopi Technologies’ Board of Directors.


Herman M. Gerwitz, CPA, 62, a director since May 2005, is the Treasurer of Keystone Property Group. Mr. Gerwitz has been with Keystone full time since 1998 and has been responsible for all the financial matters of a Real Estate Development Company that has grown to over 3 million square feet of commercial real estate and a $100,000,000 Real Estate Fund. Prior to joining Keystone, Mr. Gerwitz has spent 20 years as a partner in a public accounting firm. He has received a BBA from Temple University with master’s coursework at Widener University. He has been a member of both the Pennsylvania and American Institutes of Certified Public Accountants since 1983. The Board of Directors believes that Mr. Gerwitz’ many years as a Certified Public Accountant and his subsequent business management experience make him well suited to serve as a member of Nocopi Technologies’ Board of Directors and to serve on its Audit Committee.


Richard Levitt, 59, a director since December 1999, has been engaged in the computer and services segment of the computer industry since 1981. Mr. Levitt is currently a Senior Account Executive for Dell Computer in Pittsburgh, PA. He is in the Large Enterprise Group and is responsible for developing major accounts in Western Pennsylvania. Mr. Levitt has been with Dell since November 2005. In 2009, Mr. Levitt was awarded the “Circle of Excellence” award by Dell which is Dell’s highest corporate award given to less than 1% of its sales and support employees. In addition, he was awarded over the past three years the “Top Team Performer” and “Regional Top Performer” awards. In 1995, he participated in the founding of XiTech Corporation, a Pittsburgh, Pennsylvania-based provider of computing and computer networking hardware and network design and implementation services which in five years grew to over 100 employees and $50 million in annual sales. Since founding XiTech, Mr. Levitt served as one of its corporate principals, as a Network Consultant and as the Manager of its Network Sales Force. Mr. Levitt left XiTech in 2004. Before joining XiTech, Mr. Levitt served as a network sales executive for Digital Equipment Corporation from 1988 to 1994 and as a network consultant for TriLogic Corporation during 1994 and 1995. Mr. Levitt holds a B.S. in Marketing from Kent State University. The Board of Directors believes that Mr. Levitt’s sales and marketing experience in technology-based businesses, including start-ups and smaller businesses, makes him well suited to serve as a member of Nocopi Technologies’ Board of Directors.


Philip B. White, 77, has been a director since August 2006. Mr. White is currently an international consultant in the private sector providing regulatory and industry standards advice to international companies regulated by the Food and Drug Administration, the Consumer Product Safety Commission, and the Environmental Protection Agency. He also served as a Technical Advisor and Regulatory Liaison to Nocopi from 2002 to 2005. Before establishing his own global consulting practice in 2000, Mr. White was, from 1994 to 2000, Director of Medical Device Consulting at the international firm of AAC Consulting Group (now Kendle), Rockville, MD. In 1994, Mr. White retired from a 33-year career with the U.S. Food and Drug Administration. His last FDA position was Director of the Office of Standards and Regulations in the Center for Devices and Radiological Health. Previous FDA positions included Regional Director of FDA’s enforcement activities in the Southwestern Region, Deputy FDA Assistant Commissioner for Program Coordination, and Supervisory Food and Drug Inspector. He has served on the Board of Directors of the American National Standards Institute, the Association for Advancement of Medical Instrumentation, and the Regulatory Affairs Professionals Society. He is a 1961 graduate of Wilkes University, Wilkes-Barre, PA with a B.A. Degree in Biology. He also did graduate studies in 1967 and 1968 specializing in the Federal Food Drug and Cosmetic Act at the New York University Graduate Law School in New York City. The Board of Directors believes that Mr. White’s considerable experience with consumer product safety and regulatory matters gained from his many years at the Food and Drug Administration makes him well suited to serve as a member of Nocopi Technologies’ Board of Directors.




16



 


Terry W. Stovold, 53, Chief Operating Officer, has been employed by Nocopi for more than twenty-five years. Mr. Stovold previously served as the Company’s Director of Operations and Sales. Mr. Stovold received a Forestry Technician College degree from Algonquin College and studied business at McGill University. He holds numerous U.S. and foreign patents in the fields of printing technology and printing inks.


Rudolph A. Lutterschmidt, 69, has been Vice President and Chief Financial Officer of the Company for more than five years, serving in this capacity on a part-time basis since January 2000. Mr. Lutterschmidt has been a consultant to several southeast Pennsylvania businesses. He is a graduate of Syracuse University.


The terms of the current directors will expire at the 2016 annual meeting of stockholders of the Company.


Corporate Governance


The Board of Directors has determined that all of the directors, with the exception of Michael A. Feinstein, M.D., who serves as Chief Executive Officer, are independent as that term is defined by the SEC. The Company did not make any material changes to the procedures by which stockholders may recommend nominees to the Company’s Board of Directors during 2015.


Audit Committee Financial Expert


The Company has established a standing audit committee in accordance with Section 3(a) (58) (A) of the Securities Exchange Act of 1934 that makes recommendations to the Company’s Board of Directors regarding the selection of an independent registered public accounting firm, reviews the results and scope of the Company’s audits and other accounting-related services and reviews and evaluates the Company’s internal control functions. The audit committee does not presently have a written charter. The audit committee is comprised of Michael A. Feinstein, M.D., its Chairman of the Board, and Herman M. Gerwitz, CPA. The Board of Directors has determined that Mr. Gerwitz is an “audit committee financial expert” as currently defined under the SEC rules implementing Section 407 of the Sarbanes Oxley Act of 2002 and that Mr. Gerwitz meets the criteria for independence as defined by the SEC.


Code of Ethics


The Company has adopted a Code of Ethics that applies to its Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and persons performing similar functions. A copy of the Company’s Code of Ethics is incorporated by reference to Exhibit 14.1 of this report on Form 10-K.


Section 16(a) Beneficial Ownership Reporting Compliance


Section 16(a) of the Exchange Act requires the Company’s executive officers and directors and any persons who beneficially own more than 10% of its Common Stock (collectively, “Reporting Persons”) to file reports of ownership and changes in ownership with the SEC. Reporting Persons are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file.


Based solely on the Company’s review of the copies of any Section 16(a) forms received by it, the Company believes that with respect to the fiscal year ended December 31, 2015, all Reporting Persons complied with all applicable filing requirements.



17



 


ITEM 11. EXECUTIVE COMPENSATION


The following table sets forth information concerning compensation for 2015 and 2014 earned by Michael A. Feinstein, M.D., the Company’s Chairman who has served since February 2000 as the Company’s Chief Executive Officer and Terry W. Stovold, the Company’s Chief Operating Officer, the only employee to receive compensation in 2015 greater than $100,000 (the “Named Executive”).


SUMMARY COMPENSATION TABLE


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonequity

 

 

Nonqualified

 

 

 

 

 

 

 

Name

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

incentive

 

 

deferred

 

 

 

 

 

 

 

and

 

 

 

 

 

 

 

 

 

 

Stock

 

 

Option

 

 

plan

 

 

compensation

 

 

All other

 

 

 

 

principal

 

 

 

 

Salary

 

 

Bonus

 

 

awards

 

 

awards

 

 

compensation

 

 

earnings

 

 

compensation

 

 

Total

 

position

 

Year

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

(a)

 

(b)

 

 

(c)

 

 

(d)

 

 

(e)

 

 

(f)

 

 

(g)

 

 

(h)

 

 

(i)

 

 

(j)

 

Michael A. Feinstein, M.D.

  

 

2015

  

  

 

85,000

  

  

 

 

  

  

 

 

  

  

 

 

  

  

 

 

  

  

 

 

  

  

 

 

 

  

  

 

85,000

 

Chairman, President and

 

 

2014

 

 

 

85,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

85,000

 

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                                               

 

 

           

 

 

 

            

 

 

 

            

 

 

 

              

 

 

 

             

 

 

 

                       

 

 

 

                       

 

 

 

                  

      

 

 

 

                  

 

Terry W. Stovold

 

 

2015

 

 

 

75,000

 

 

 

1,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

65,200

(1)

 

 

 

141,200

 

Chief Operating Officer

 

 

2014

 

 

 

75,000

 

 

 

1,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

55,200

(1)

 

 

 

131,200

 

———————

(1) Sales commissions


Dr. Feinstein entered into a written employment agreement effective June 1, 2008 under which he serves as President and Chief Executive Officer of the Company for an initial term of three years with successive one year renewal terms. In accordance with the terms of the employment agreement, the employment agreement renewed on December 1, 2015 for a period of one year effective June 1, 2016. The employment agreement provides for an annual base salary of $85,000 which may be increased annually at the discretion of the Board of Directors and an annual performance bonus determined by the Board of Directors. In certain situations, including a change in control, Dr. Feinstein may be eligible to receive his base salary for a period of up to twelve months following the termination of employment. The employment agreement prohibits him from competing with the Company during the term of this agreement and for two years after the termination of his employment with the Company. In each of the years ended December 31, 2015 and 2014, Dr. Feinstein deferred $85,000 of salary owed to him for each of those years. At December 31, 2015, Dr. Feinstein was owed a total of approximately $290,400 of salary deferred by him.


Mr. Stovold entered into a written employment agreement effective April 1, 2011 under which he served as the Company’s Director of Operations and Sales for an initial term of three years with successive one year renewal terms. The employment agreement provides for a base salary set by the Company’s Board of Directors, which is currently set at $75,000 per year beginning on January 1, 2012, along with a commission of seven percent on sales generated by his efforts. In certain situations, including but not limited to a change in control, Mr. Stovold may be eligible to receive his base salary for a period of up to six months following the termination of employment. The employment agreement prohibits him from competing with the Company during the term of the agreement and for one year after the termination of his employment with the Company. At December 31, 2015, Mr. Stovold was owed approximately $33,500 of currently payable commissions related to sales realized in 2015 through his efforts. In July 2014, the Company’s Board of Directors appointed Mr. Stovold Chief Operating Officer of the Company. There were no changes to the employment agreement with Mr. Stovold resulting from this appointment.


There are no outstanding stock or option awards at fiscal year end.


If Dr. Feinstein’s employment is terminated as a result of a change in control, Dr. Feinstein is entitled to receive severance payments equal to twelve months of his then base salary. If Mr. Stovold’s employment is terminated as a result of a change in control, Mr. Stovold is entitled to receive severance payments not to exceed six months of his then base salary.




18



 


Director Compensation


The following table summarizes compensation earned by the Company’s non-executive directors for the year ended December 31, 2015. All directors have been and will be reimbursed for reasonable expenses incurred in connection with attendance at meetings of the Board of Directors or other activities undertaken by them on behalf of the Company.


DIRECTOR COMPENSATION


 

 

 

 

 

 

 

 

 

 

 

Nonequity

 

 

Nonqualified

 

 

 

 

 

 

 

 

 

Fees

 

 

 

 

 

 

 

 

incentive

 

 

deferred

 

 

 

 

 

 

 

 

 

earned or

 

 

Stock

 

 

Option

 

 

plan

 

 

compensation

 

 

All other

 

 

 

 

 

 

paid in cash

 

 

awards

 

 

awards

 

 

compensation

 

 

earnings

 

 

compensation

 

 

Total

 

Name

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

(a)

 

(b)

 

 

(c)

 

 

(d)

 

 

(e)

 

 

(f)

 

 

(g)

 

 

(h)

 

Herman M. Gerwitz (1)

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Richard Levitt

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Philip B. White

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

———————

(1) At December 31, 2015, Mr. Gerwitz held 26,665 warrants that become exercisable in July 2016.


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS


The following table sets forth, as of March 15, 2016, the stock ownership of (1) each person or group known by the Registrant to beneficially own 5% or more of Registrant’s Common Stock and (2) each director and Named Executive (as set forth under the heading “Executive Compensation”) individually, and (3) all directors and executive officers of the Company as a group. To the Company’s knowledge, except as set forth in the footnotes to this table and subject to applicable community property laws, each person named in the table below has sole voting and investment power with respect to the shares set forth opposite such person’s name. Except as otherwise indicated, the address of each of the persons in the table below is c/o Nocopi Technologies, Inc., 480 Shoemaker  Road, Suite 104, King of Prussia, Pennsylvania, 19406.


Common Stock


 

 

Number

 

 

 

 

 

 

of Shares

 

 

Percentage

 

 

 

Beneficially

 

 

of

 

Name of Beneficial Owner

 

Owned

 

 

Class (1)

 

5% Stockholders

 

 

 

 

 

 

Philip N. Hudson

P.O. Box 160892

San Antonio, TX 78280-3092 (2) 

 

 

5,687,918

 

 

 

9.7

%

Westvaco Brand Security, Inc.

One High Ridge Park

Stamford, CT 06905 (3)

 

 

3,917,030

 

 

 

6.7%

 

Ross. L Campbell

675 Lewis Lane

Ambler, PA 19002 (4)

 

 

3,264,457

 

 

 

5.6

%

 

 

 

 

 

 

 

 

 

Directors, Officers and Named Executive

 

 

 

 

 

 

 

 

Michael A Feinstein, M.D. (5)

 

 

3,109,881

 

 

 

5.3

%

Herman M. Gerwitz (6)

 

 

376,549

 

 

 

*

 

Richard Levitt

 

 

299,000

 

 

 

*

 

Philip B. White (7)

 

 

286,745

 

 

 

*

 

Terry W. Stovold

 

 

0

 

 

 

*

 

All Executive Officers and Directors as a Group (6 individuals)

 

 

4,069,775

 

 

 

6.9

%

———————

* Less than 1.0%.



19



 



(1)

Where the Number of Shares Beneficially Owned (reported in the preceding column) includes shares which may be purchased upon the exercise of outstanding stock options and warrants which are or within sixty days will become exercisable (“presently exercisable options”) the percentage of class reported in this column has been calculated assuming the exercise of such presently exercisable options.

(2)

As reflected in a Schedule 13D dated August 11, 2008 filed on behalf of Philip N. Hudson and subsequent open market purchases as reported to the Company by Mr. Hudson.

(3)

As reflected in a Schedule 13D dated March 14, 2001 filed on behalf of Westvaco Brand Security, Inc.

(4)

As reflected in a Schedule 13D dated April 4, 2005 filed on behalf of Ross L. Campbell.

(5)

Includes 734,000 shares held by a pension plan of which Dr. Feinstein is the trustee and 100,000 shares held in an IRA.

(6)

Includes 50,000 shares held by a trust on behalf of a child of Mr. Gerwitz, 72,500 shares held by a child of Mr. Gerwitz and 6,000 shares held in an IRA.

(7)

Includes 5,000 shares held by Mr. White’s wife.


EQUITY COMPENSATION PLAN INFORMATION AS OF DECEMBER 31, 2015


Plan Category

 

Number of securities to be issued upon exercise of outstanding options, warrants and rights

 

 

Weighted-average exercise price of outstanding options, warrants and rights compensation plans

 

 

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

 

 

 

(a)

 

 

(b)

 

 

(c)

 

 

  

                         

  

  

                         

  

  

                         

  

Warrants issued in connection with convertible debentures, short-term loans and financing considerations (1)

 

 

756,365

 

 

$

0.022

 

 

 

-0-

 

Total

 

 

756,365

 

 

$

0.022

 

 

 

-0-

 

———————

(1)

Warrants issued in connection with the sale of convertible debentures totaling $138,273 in 2014 and 2013, the receipt of short term-notes totaling $45,000 from 2011 through 2013, and, in 2011, to a professional services provider related to certain fee payment considerations were approved by the Board of Directors. The warrants expire from five to seven years from the date of issuance.


ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE


During 2014, with the approval of the disinterested members of the Board of Directors, the Company exchanged a $4,500 short-term loan held by Herman M. Gerwitz, a Director, together with accrued interest, for a $5,333 convertible debenture which included warrants to purchase 26,665 shares of the Company’s Common Stock at $0.02 per share. The warrant is exercisable two years after issuance and expires seven years after issuance. The debenture is due in two years. At the option of the lender, the debenture and accrued interest is convertible in whole or part into Common Stock of the Company at $0.05 per share.


During 2014, with the approval of the disinterested members of the Board of Directors, the Company exchanged a $20,000 short-term loan held by Dr. Feinstein’s brother-in-law together with accrued interest, for a $22,940 convertible debenture which included warrants to purchase 114,700 shares of the Company’s Common Stock at $0.02 per share. The warrant is exercisable two years after issuance and expires seven years after issuance. The debenture is due in two years. At the option of the lender, the debenture and accrued interest is convertible in whole or part into Common Stock of the Company at $0.05 per share.  


The Board of Directors has determined that all the directors, with the exception of Michael A. Feinstein, M.D., who serves as President and Chief Executive Officer, are independent as that term is defined by the SEC.




20



 


ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES


Registrant has retained the public accounting firm of Morison Cogen LLP, whose principal business address is 484 Norristown Road, Suite 100, Blue Bell, PA 19422, to perform its annual audit for inclusion of its report in Form 10-K and perform SAS 100 reviews of quarterly information in connection with Form 10-Q filings.


Audit Fees


During 2015 and 2014, the aggregate fees billed for professional services rendered by Registrant’s principal accountant for the audit of Registrant’s annual financial statements and review of its quarterly financial statements were $47,000 and $35,000, respectively.


Audit-Related Fees


During 2015 and 2014, there were no fees billed for audit-related services.


Tax Fees


During 2015 and 2014, the aggregate fees billed for professional services rendered by Registrant’s principal accountant for tax compliance, tax advice and tax planning were $9,000 and $0, respectively.


All Other Fees


During 2015 and 2014, there were no fees billed for products and services provided by Registrant’s principal accountant other than those set forth above.  


Audit Committee Approval


The Audit Committee, consisting of Michael A. Feinstein, M.D., Chairman, President and Chief Executive Officer, and Herman M. Gerwitz, CPA, evaluate and approve, in advance, the scope and cost of the engagement of an auditor before the auditor renders audit and non-audit services. All non-audit services were approved by the audit committee. Registrant does not rely on pre-approval policies and procedures.


ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES


See Exhibit Index.




21



 


SIGNATURES


Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

NOCOPI TECHNOLOGIES, INC.

 

 

 

 

 

 

Date: March 30, 2016

By:

/s/ Michael A. Feinstein, M.D.

 

 

Michael A. Feinstein, M.D.

 

Title:

Chairman of the Board, President and Chief Executive Officer



Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



Signature

 

Title

 

Date

 

 

 

 

 

/s/ Michael A. Feinstein, M.D.

     

Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)

     

March 30, 2016

Michael A. Feinstein, M.D.

 

 

 

 

 

 

 

 

/s/ Rudolph A. Lutterschmidt

 

Vice President, Chief Financial Officer and Chief Accounting Officer (Principal Financial and Accounting Officer)

 

March 30, 2016

Rudolph A. Lutterschmidt

 

 

 

 

 

 

 

 

/s/ Herman M. Gerwitz

 

Director

 

March 30, 2016

Herman M. Gerwitz

 

 

 

 

 

 

 

 

 

/s/ Richard Levitt

 

Director

 

March 30, 2016

Richard Levitt

 

 

 

 

 

 

 

 

 

/s/ Philip B. White

 

Director

 

March 30, 2016

Philip B. White

 

 

 

 














22



 


INDEX TO FINANCIAL STATEMENTS


Report of Independent Registered Public Accounting Firm

F-2

 

 

Balance Sheets as of December 31, 2015 and 2014

F-3

 

 

Statements of Operations for the Years ended December 31, 2015 and 2014

F-4

 

 

Statement of Stockholders’ Deficiency for the Years ended December 31, 2015 and 2014

F-5

 

 

Statements of Cash Flows for the Years ended December 31, 2015 and 2014

F-6

 

 

Notes to Financial Statements

F-7








F-1



 


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Stockholders and Board of Directors

 of Nocopi Technologies, Inc.

King of Prussia, Pennsylvania


We have audited the accompanying balance sheets of Nocopi Technologies, Inc. as of December 31, 2015 and 2014, and the related statements of operations, stockholders' deficiency, and cash flows for each of the two years in the period ended December 31, 2015. Nocopi Technologies, Inc.’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.


We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.


In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Nocopi Technologies, Inc. at December 31, 2015 and 2014, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2015 in conformity with accounting principles generally accepted in the United States of America.


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company continues to have a working capital deficit which raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to this matter are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.





/s/ MORISON COGEN LLP



Blue Bell, Pennsylvania

March 30, 2016







F-2



 


Nocopi Technologies, Inc.

Balance Sheets*


 

 

December 31.

 

 

 

2015

 

 

2014

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$

11,400

 

 

$

28,000

 

Accounts receivable less $5,000 allowance for doubtful accounts

 

 

253,300

 

 

 

287,800

 

Inventory

 

 

36,600

 

 

 

43,500

 

Prepaid and other

 

 

22,600

 

 

 

18,800

 

Total current assets

 

 

323,900

 

 

 

378,100

 

 

 

 

 

 

 

 

 

 

Fixed assets

 

 

 

 

 

 

 

 

Leasehold improvements

 

 

19,700

 

 

 

19,700

 

Furniture, fixtures and equipment

 

 

176,900

 

 

 

176,800

 

 

 

 

196,600

 

 

 

196,500

 

Less: accumulated depreciation and amortization

 

 

175,700

 

 

 

178,400

 

 

 

 

20,900

 

 

 

18,100

 

Total assets

 

$

344,800

 

 

$

396,200

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Deficiency

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Demand loans

 

$

23,500

 

 

$

63,000

 

Convertible debentures

 

 

32,800

 

 

 

102,900

 

Accounts payable

 

 

76,200

 

 

 

160,300

 

Accrued expenses

 

 

443,000

 

 

 

383,000

 

Deferred revenue

 

 

112,400

 

 

 

93,400

 

Total current liabilities

 

 

687,900

 

 

 

802,600

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible debentures, net of unaccreted discount of $0 at December 31, 2015 and $1,400 at December 31, 2014

 

 

95,000

 

 

 

31,800

 

 

 

 

 

 

 

 

 

 

Stockholders’ deficiency

 

 

 

 

 

 

 

 

Series A preferred stock, $1.00 par value

 

 

 

 

 

 

 

 

Authorized - 300,000 shares

 

 

 

 

 

 

 

 

Issued and outstanding - none

 

 

 

 

 

 

Common stock, $0.01 par value

 

 

 

 

 

 

 

 

Authorized - 75,000,000 shares

 

 

 

 

 

 

 

 

Issued and outstanding - 58,599,016 shares

 

 

586,000

 

 

 

586,000

 

Paid-in capital

 

 

12,426,600

 

 

 

12,408,500

 

Accumulated deficit

 

 

(13,450,700

)

 

 

(13,432,700

)

 

 

 

(438,100

)

 

 

(438,200

)

Total liabilities and stockholders’ deficiency

 

$

344,800

 

 

$

396,200

 



*The accompanying notes are an integral part of these financial statements.





F-3



 


Nocopi Technologies, Inc.

Statements of Operations*


 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

Licenses, royalties and fees

 

$

338,700

 

 

$

358,800

 

Product and other sales

 

 

612,100

 

 

 

564,000

 

 

 

 

950,800

 

 

 

922,800

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

 

 

 

 

 

Licenses, royalties and fees

 

 

77,000

 

 

 

75,600

 

Product and other sales

 

 

256,000

 

 

 

248,700

 

 

 

 

333,000

 

 

 

324,300

 

Gross profit

 

 

617,800

 

 

 

598,500

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

Research and development

 

 

128,100

 

 

 

121,600

 

Sales and marketing

 

 

202,800

 

 

 

194,500

 

General and administrative

 

 

325,600

 

 

 

253,400

 

 

 

 

656,500

 

 

 

569,500

 

Net income (loss) from operations

 

 

(38,700

)

 

 

29,000

 

 

 

 

 

 

 

 

 

 

Other income (expenses)

 

 

 

 

 

 

 

 

Reversal of accounts payable

 

 

56,300

 

 

 

 

Interest income

 

 

 

 

 

300

 

Interest expense, bank charges, financing cost and accretion of interest

 

 

(35,600

)

 

 

(21,600

)

 

 

 

20,700

 

 

 

(21,300

)

Net income (loss)

 

$

(18,000

)

 

$

7,700

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share

 

 

 

 

 

 

 

 

Basic

 

(.00

)

 

$

.00

 

Diluted

 

(.00

)

 

$

.00

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

Basic

 

 

58,599,016

 

 

 

58,599,016

 

Diluted

 

 

58,599,016

 

 

 

58,600,690

 




*The accompanying notes are an integral part of these financial statements.





F-4



 


Nocopi Technologies, Inc.

Statement of Stockholders’ Deficiency*

For the Period January 1, 2014 through December 31, 2015


 

 

Common stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - January 1, 2014

 

 

58,599,016

 

 

$

586,000

 

 

$

12,406,600

 

 

$

(13,440,400

)

 

$

(447,800

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants issued to convertible debenture holders

 

 

 

 

 

 

 

 

 

 

1,900

 

 

 

 

 

 

 

1,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,700

 

 

 

7,700

 

Balance - December 31, 2014

 

 

58,599,016

 

 

 

586,000

 

 

 

12,408,500

 

 

 

(13,432,700

)

 

 

(438,200

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt discount to convertible debentures

 

 

 

 

 

 

 

 

 

 

18,100

 

 

 

 

 

 

 

18,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(18,000

)

 

 

(18,000

)

Balance - December 31, 2015

 

 

58,599,016

 

 

$

586,000

 

 

$

12,426,600

 

 

$

(13,450,700

)

 

$

(438,100

)




*The accompanying notes are an integral part of these financial statements.






F-5



 


Nocopi Technologies, Inc.

Statements of Cash Flows*


 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

Operating Activities

 

 

 

 

 

 

Net income (loss)

 

(18,000

)

 

$

7,700

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

6,100

 

 

 

4,000

 

Reversal of accounts payable

 

 

(56,300

)

 

 

 

Accretion of interest – convertible debentures

 

 

21,200

 

 

 

4,600

 

 

 

 

(47,000

)

 

 

16,300

 

 

 

 

 

 

 

 

 

 

(Increase) decrease in assets

 

 

 

 

 

 

 

 

Accounts receivable

 

 

34,500

 

 

 

(50,700

)

Inventory

 

 

6,900

 

 

 

(15,000

)

Prepaid and other

 

 

(3,800

)

 

 

12,700

 

Increase (decrease) in liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

32,200

 

 

 

71,600

 

Deferred revenue

 

 

19,000

 

 

 

(20,400

)

 

 

 

88,800

 

 

 

(1,800

)

Net cash provided by operating activities

 

 

41,800

 

 

 

14,500

 

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Additions to fixed assets

 

 

(8,900

)

 

 

(20,600

)

Net cash used in investing activities

 

 

(8,900

)

 

 

(20,600

)

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Repayment of borrowings under promissory note

 

 

 

 

 

(18,800

)

Repayment of demand loans

 

 

(39,500

)

 

 

(5,000

)

Proceeds from convertible debenture

 

 

 

 

 

5,000

 

Repayment of convertible debenture

 

 

(10,000

)

 

 

 

Net cash used in financing activities

 

 

(49,500

)

 

 

(18,800

)

Decrease in cash

 

 

(16,600

)

 

 

(24,900

)

Cash

 

 

 

 

 

 

 

 

Beginning of year

 

 

28,000

 

 

 

52,900

 

End of year

 

$

11,400

 

 

$

28,000

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

7,700

 

 

$

300

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of Non Cash Investing Activities

 

 

 

 

 

 

 

 

Write-off of fully depreciated leasehold improvements and furniture fixtures and equipment

 

 

 

 

 

 

 

 

Accumulated depreciation and amortization

 

(8,800

)

 

(82,900

)

Leasehold improvements

 

 

 

 

$

72,500

 

Furniture, fixtures and equipment

 

$

8,800

 

 

$

10,400

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Non Cash Financing Activities

 

 

 

 

 

 

 

 

Conversion of demand loans and interest to convertible debentures

 

 

 

 

 

 

 

 

Demand loans

 

 

 

 

(24,500

)

Accrued expenses

 

 

 

 

(3,800

)

Convertible debentures

 

 

 

 

$

26,400

 

Paid-in capital

 

 

 

 

$

1,900

 



*The accompanying notes are an integral part of these financial statements.





F-6



 


NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014


1.

Organization of the Company


Nocopi Technologies, Inc. (the “Company”) is organized under the laws of the State of Maryland. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the Entertainment and Toy and the Document and Product Authentication markets in the United States and foreign countries. The Company operates in one principal industry segment.


2.

Significant Accounting Policies


Financial Statement Presentation - Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.


Estimates - The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.


Cash consists of demand deposits with a major U.S. bank.


Accounts receivable and credit policies - Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.


The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.


Inventory consists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or market.


Fixed assets are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.


Patent costs are charged to expense as incurred due to the uncertainty of their recoverability as a result of the Company’s adverse liquidity situation.


Revenues - In accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 605, Revenue Recognition, the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to these criteria, the Company will generally recognize revenue upon shipment of product. Revenue from license fees and royalties will be recognized as earned over the license term.


Income taxes - Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.





F-7



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


Fair value - The carrying amounts reflected in the balance sheets for cash, receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. The carrying amount of the demand loans and the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.


Convertible debentures, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.


Stock-based payments - the Company accounts for stock-based compensation under the provisions of FASB ASC 718, "Compensation - Stock Compensation" which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, "Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders’ equity over the applicable service periods. Non-employee equity based payments that do not vest immediately upon grant are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed.


Earnings (loss) per share - The Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share. Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.


The table below presents the computation of basic and diluted weighted average common shares outstanding:


 

 

2015

 

 

2014

 

Basic shares outstanding

 

 

58,599,016

 

 

 

58,599,016

 

Incremental shares from assumed conversion of warrants

 

 

 

 

 

1,674

 

Diluted shares outstanding

 

 

58,599,016

 

 

 

58,600,690

 


Comprehensive income (loss) - The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net income (loss).




F-8



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


Recoverability of Long-Lived Assets


The Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.  The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company’s annual financial statements.


Recently Adopted Accounting Pronouncements


As of December 31, 2015 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.


Recently Issued Accounting Pronouncements Not Yet Adopted


In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments in this Update provide guidance about management’s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued and to provide related footnote disclosures. Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management is assessing the impact of the adoption to the financial statements.


3.

Going Concern


Since its inception, with the exception of the years ended December 31, 2007 and December 31, 2013 and December 13, 2014, during which it generated net income of $386,000 and $10,300 and $7,700, respectively, the Company has incurred significant losses and, as of December 31, 2015, had accumulated losses of $13,450,700. For the year ended December 31, 2015, the Company had a net loss from operations of $38,700. For the year ended December 31, 2014 Company’s had net income from operations of $29,000. The Company had negative working capital of $364,000 at December 31, 2015 and $424,500 at December 31, 2014. Due in part to uncertainties in the US economy, the Company, which is substantially dependent on its licensees to generate licensing revenues, may incur further operating losses and experience negative cash flow in the future. Achieving profitability and positive cash flow depends on the Company’s ability to generate and sustain significant increases in revenues and gross profits from its traditional business. There can be no assurances that the Company will be able to generate sufficient revenues and gross profits to sustain profitability and return to positive cash flow in the future.


During 2014, the Company sold a $5,000 convertible debenture to an investor. Receipt of funds in earlier periods from investors and from demand loan holders have allowed the Company to remain in operation through the current date. Management of the Company believes that it may need additional capital in the future both to fund investments needed to increase its operating revenues to levels that will sustain its operations and to fund operating deficits that it anticipates will continue until revenue increases from traditional and new product lines can be realized. There can be no assurances that the Company will be successful in obtaining sufficient additional capital, or if it does, that the additional capital will enable the Company to impact its revenues so as to have a material positive effect on the Company’s operations and cash flow. The Company believes that without additional capital, whether in the form of debt, equity or both, it may be forced to cease operations at an undetermined future date.




F-9



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


The Company’s independent registered public accountants have included a “going concern” explanatory paragraph in their audit report accompanying the 2015 financial statements. The paragraph states that the Company’s continuing working capital deficit raises substantial doubt about the Company’s ability to continue as a going concern and cautions that the financial statements do not include any adjustments that might result from the outcome of this uncertainty.


4.

Concentration of Credit Risk


Certain financial instruments potentially subject the Company to concentrations of credit risk.  These financial instruments consist primarily of cash and accounts receivables. At December 31, 2015, the Company did not have deposits with a financial institution that exceed the FDIC deposit insurance coverage of $250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.


5.

Demand Loans


At December 31, 2015 and December 31, 2014, the Company had unsecured loans totaling $23,500 from two individuals and $63,000 from three individuals, respectively, outstanding. The loans bear interest at 8%. During the year ended December 31, 2015, the Company repaid $39,500 of the unsecured loans along with approximately $6,300 of accrued interest. During the year ended December 31, 2014, the Company repaid $5,000 of the unsecured loans.


6.

Promissory Note


In early July 2014, the Company repaid the $6,250 remaining balance of a $100,000 promissory note with a bank. The promissory note resulted from the conversion in September 2010 of an outstanding line of credit with the bank. The promissory note was payable in forty-eight equal monthly installments, beginning in October 2010, of $2,083, plus interest at the bank’s prime rate of interest plus 0.5%. The interest rate throughout the term of the promissory note was 3.75%.


7.

Convertible Debentures


At December 31, 2015, the Company had convertible debentures totaling $127,800 outstanding, of which $32,800 are due during the third quarter of 2016 and $95,000 are due during the third quarter of 2017. The convertible debentures bear interest at 7%. At the option of the lender, $95,000 principal of the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.025 per share and $32,800 principal of the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. In July 2015, the Company repaid, with interest, a $10,000 convertible debenture that had matured. During the third quarter of 2015, the Company’s Board of Directors approved and the holders of $95,000 of convertible debentures maturing during the third quarter of 2015 accepted an offer of extension whereby the maturity dates of the convertible debentures are extended for two years and the conversion rate of the debentures and accrued interest into Common Stock of the Company is reduced from $0.05 to $0.025. In accordance with FASB ASC 470, this modification of the convertible debentures was recorded as a debt discount to the notes payable of approximately $18,100 with an offsetting credit to additional-paid in capital. In the year ended December 31, 2015, the entire $18,100 was accreted through interest expense.


During the third quarter of 2014, the Company, with the approval of its Board of Directors, exchanged two demand loans totaling $24,500 including one demand loan in the amount of $4,500 held by Herman M. Gerwitz, a Director, along with approximately $3,800 of accrued interest for convertible debentures totaling approximately $28,300. The debentures bear interest at 7% and are due and payable two years from the date of issuance. At option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 141,365 shares of common stock of the Company at $0.02 per share to the debenture holders. The warrants are exercisable two years after issuance and expire seven years after issuance.




F-10



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


During the third quarter of 2014, the Company received $5,000 through the issuance of a convertible debenture to an investor. The debenture bears interest at 7% and is due and payable two years from the date of issuance. At option of the lender, the debenture and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 25,000 shares of the Company’s common stock at $0.02 per share to the holder of the debenture. The warrants are exercisable two years after issuance and expire seven years after issuance.


Additionally, the Company has warrants to purchase 525,000 shares of the Company’s common stock at $0.02 per share outstanding that were granted in conjunction with the issuance of $105,000 of convertible debentures to seven investors in 2013. The warrants are exercisable two years after issuance and expire seven years after issuance.


The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since the Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances is being accreted through interest expense over the term of the notes payable. For the years ended December 31, 2015 and December 31, 2014, approximately $3,100 and $4,600, respectively, was accreted through interest expense.


8.

Stockholders' Deficiency


In July 2015, the common stock private placement was extended to December 31, 2016 by the Company’s Board of Directors.


9.

Other Income (Expenses)


Other income (expenses) includes, in 2015, the reversal of approximately $56,300 of accounts payable related to invoices received from 2001 through 2009 from a professional services business that provided legal services to the Company and an individual that provided consulting services to the Company in 2009 that the Company, with legal counsel, has determined to be no longer statutorily payable as the statute of limitations to bring claims has expired. Additionally, other income (expenses) includes interest on unsecured loans from five individuals, on convertible debentures held by ten investors and, in 2014, on funds borrowed under the Company’s promissory note with a bank. Also included in other income (expenses) is accretion of debt discounts related to the issuance of convertible debentures totaling $128,400 and, in 2015, the extension of the maturity dates of $95,000 of convertible debentures.


10.

Income Taxes


There is no income tax benefit for the year ended December 31, 2015 due to the availability of net operating loss carryforwards (“NOL’s”) for which the Company had previously established a 100% valuation allowance for deferred tax assets due to the uncertainty of their recoverability. There is no provision for income taxes for the year ended December 31, 2014 due to the availability of net operating loss carryforwards. At December 31, 2015 and December 31, 2014, the Company had NOL’s approximating $4,627,000 and $4,601,000, respectively. The operating losses at December 31, 2015 are available to offset future taxable income; however, if not utilized, they expire in varying amounts through the year 2035. As a result of the sale of the Company's common stock in an equity offering in late 1997 and the issuance of additional shares, the amount of the NOL’s may be limited. Additionally, the utilization of these NOL’s, if available, to reduce future income taxes will depend on the generation of sufficient taxable income prior to their expiration. There were no material temporary differences for the years ended December 31, 2015 and December 31, 2014. The Company has established a 100% valuation allowance of approximately $1,943,000 and $1,933,000 at December 31, 2015 and December 31, 2014, respectively, for the deferred tax assets due to the uncertainty of their realization.


The Company has adopted the provisions of FASB ASC 740-10-50-15, “Unrecognized Tax Benefit Related Disclosures.” There were no unrecognized tax benefits as of the date of adoption and no unrecognized tax benefits at December 31, 2015. There was no change in unrecognized tax benefits during the year ended December 31, 2015 and there was no accrual for uncertain tax positions as of December 31, 2015.




F-11



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


There were no interest and penalties recognized in the statement of operations and in the balance sheet. Tax years from 2011 through 2015 remain subject to examination by U.S. federal and state tax jurisdictions.


11.

Related Party Transactions


In each of the years ended December 31, 2015 and December 31, 2014, Michael A. Feinstein, M.D., the Company’s Chairman of the Board and Chief Executive Officer, deferred $85,000 of salary owed to him under an employment agreement with the Company. At December 31, 2015 and December 31, 2014, Dr. Feinstein was owed $290,400 and $215,400, respectively, of salary that was deferred by him in response to the adverse liquidity experienced by the Company beginning in 2012. There are no formal terms or arrangements for repayment of the deferred salary. In December 2015 and January 2016, the Company made payments of $10,000 and $15,000, respectively, to Dr. Feinstein, representing a portion of amounts owed to him. There is no interest payable on the deferred salary.  


12.

Commitments and Contingencies


The Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2019.


Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at December 31, 2015 are: $46,200 – 2016; $47,400 – 2017; $48,600 – 2018 and $16,300 – 2019.


Total rental expense under operating leases was $44,800 and $45,100 in 2014 and 2015, respectively.


The Company has an employment agreement, expiring in May 2017, with Michael A. Feinstein, M.D., its Chairman of the Board and Chief Executive Officer. The employment agreement contains one-year renewal provisions that became effective after the original term. Dr. Feinstein receives base compensation of $85,000 per year plus a performance bonus determined by the Company’s Board of Directors. The Company has an employment agreement, expiring in March 2017, with Terry W. Stovold, its Chief Operating Officer, whereby Mr. Stovold receives a salary set by the Company’s Board of Directors, currently set at $75,000, along with a commission of seven percent on sales generated by his efforts. The employment agreement contains one-year renewal provisions that became effective after the original term. Future minimum compensation payments under these employment agreements are: $160,000 to be paid in 2016 and $54,200 to be paid in 2017.


From time to time, the Company may be subject to legal proceedings and claims that arise in the ordinary course of its business.


13.

Stock Options, Warrants and 401(k) Savings Plan


The Company follows FASB ASC 718, Share Based Payment, which requires that the cost resulting from all share-based payment transactions be recognized in the Company’s financial statements. FASB ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values.


The 1999 Stock Option Plan provided for the granting of up to 2,000,000 incentive and non-qualified stock options to employees, non-employee directors, consultants and advisors to the Company. In the case of options designated as incentive stock options, the exercise price of the options granted must be not less than the fair market value of such shares on the date of grant. Non-qualified stock options may be granted at any amount established by the Stock Option Committee or, in the case of Discounted Options issued to non-employee directors in lieu of any portion of an Annual Retainer, in accordance with a formula designated in the Plan. The 1999 Stock Option Plan terminated in February 2009 and no further stock options can be granted under the plan; however, options granted before the termination date could be exercised through their expiration date.


The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no compensation expense recognized during the years ended December 31, 2015 and December 31, 2014 and there was no unrecognized portion of expense at December 31, 2015.



F-12



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


A summary of stock options under the Company’s stock option plans follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2013

 

245,000

 

 

0.12

 

 

0.12

 

Options expired

 

245,000

 

 

0.12

 

 

0.12

 

Outstanding at December 31, 2014 and 2015

 

0

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

  

 

 

Option

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

 

 

 

 

 

 

 

Exercisable options at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options available for future grant:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

0

 

 

 

 

 

 

 

 

 


At December 31, 2015, the Company had 756,365 warrants to purchase common stock of the Company outstanding at exercise prices ranging from $0.01 to $0.07 and expiring at various dates through July 2021. The warrants are held by ten investors who acquired convertible debentures from the Company in 2013 and 2014 and by three individuals who provided loans and professional services to the Company.


A summary of outstanding warrants follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2013

 

660,500

 

 

0.01 to 0.07

 

 

0.026

 

Warrants granted

 

166,365

 

 

0.02

 

 

0.02

 

Warrants canceled

 

24,500

 

 

0.03 and 0.07

 

 

0.037

 

Outstanding at December 31, 2014

 

802,365

 

 

0.01 to 0.07

 

 

0.025

 

Warrants expired

 

46,000

 

 

0.06 and 0.07

 

 

0.068

 

Outstanding at December 31, 2015

 

756,365

 

 

$0.01 to $0.07

 

 

$0.022

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

4.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Exercise

 

 

 

Average

 

 

 

 

 

 

 

Price Range

 

 

 

Exercise

 

 

 

Shares

 

 

 

Per Share

 

 

 

Price

 

Exercisable warrants at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

590,000

 

 

$0.01 to $0.07

 

 

$0.023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

4.23

 

 

 

 

 

 

 

 

 


At December 31, 2015, the Company has reserved 5,846,989 shares of common stock for possible future issuance upon exercise of 756,365 warrants and for the conversion of approximately $128,300 of convertible debentures and accrued interest into 5,090,624 shares of common stock.




F-13



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2015 and 2014

 


The Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of the Company. There were no contributions charged to expense during 2015 or 2014.


14.

Major Customer and Geographic Information


The Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were:


 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

Customer A

 

 

53

%

 

 

47

%

Customer B

 

 

17

%

 

 

19

%


The Company’s non-affiliate customers whose individual balances amounted to more than 10% of the Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:


 

 

December 31

 

 

 

2015

 

 

2014

 

 Customer A

 

 

31

%

 

 

46

%

 Customer B

 

 

25

%

 

 

35

%


The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on the Company’s business operations and financial condition.


The Company’s revenues by geographic region are as follows:


 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

North America

 

$

433,000

 

 

$

477,100

 

Asia

 

 

511,600

 

 

 

445,700

 

Australia

 

 

6,200

 

 

 

 

 

 

$

950,800

 

 

$

922,800

 


15.

Subsequent Event


In March 2016, the Company repaid $4,000 of the principal of the outstanding demand loans.










 



F-14



 


Exhibit Index


The following Exhibits are filed as part of this Annual Report on Form 10-K:


Exhibit

 

 

Number

 

Description

                      

    

 

3.1

 

Amended and Restated Articles of Incorporation (17)

3.2

 

Amended and Restated Bylaws (18)

4.1

 

Form of Certificate of Common Stock (14)

10.1†

 

Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan (1)

10.2†

 

Nocopi Technologies, Inc. 1998 Stock Incentive Plan (2)

10.3†

 

Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan (3)

10.4

 

Director Indemnification Agreement (4)

10.5

 

Officer Indemnification Agreement (5)

10.6

 

Stock Purchase Agreement with Westvaco Brand Security, Inc. (6)

10.7

 

Registration Rights Agreement with Westvaco Brand Security, Inc. (7)

10.8

 

Subscription Agreement with Entrevest I Associates (8)

10.9

 

Lease Agreement dated March 19, 2003 relating to premises at 9 Portland Road, West Conshohocken, PA 19428 (9)

10.10

 

Settlement Agreement with Euro-Nocopi, S.A. (10)

10.11

 

Agreement of Terms with Entrevest I Associates (11)

10.12

 

Conversion Agreement (12)

10.13

 

Amendment dated July 18, 2007 to Lease Agreement dated March 19, 2003 relating to premises at 9 Portland Road, West Conshohocken, PA 19428 (15)

10.14†

 

Employment Agreement with Michael A. Feinstein, M.D. (16)

10.15

 

Business Loan Agreement, Promissory Note and Commercial Security Agreement dated August 19, 2008 between the Company and Sovereign Bank (19)

10.16†

 

Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan (20)

10.17†

 

Employment Agreement with Terry W. Stovold (21)

10.18

 

Conversion Agreement (22)

10.19

 

Form of Convertible Debenture Purchase Agreement and Exhibits (23)

10.20

 

Lease Agreement dated December 12, 2013 relating to premises at 480 Shoemaker Road, King of Prussia, PA 19406 (24)

14.1

 

Code of Ethics (13)

31.1*

 

Certification of Chief Financial Officer required by Rule 13a-14(a)

31.2*

 

Certification of Chief Executive Officer required by Rule 13a-14(a)

32.1*

 

Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

 

XBRL Instance Document

101.SCH*

 

XBRL Taxonomy Extension Schema Document

101.CAL*  

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

 

XBRL Taxonomy Extension Label Linkbase

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase Document

———————

*

    

Exhibit filed with this Report.

 

Compensation plans and arrangements for executives and others.

(1)

 

Incorporated by reference to Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 1993

(2)

 

Incorporated by reference to Exhibit 10.14 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 1998 filed on April 15, 1999

(3)

 

Incorporated by reference to Exhibit 10.15 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 1998 filed on April 15, 1999

(4)

 

Incorporated by reference to Exhibit 10.19 of the Registrant’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 1999 filed on November 15, 1999

(5)

 

Incorporated by reference to Exhibit 10.20 of the Registrant’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 1999 filed on November 15, 1999







 



(6)

 

Incorporated by reference to Exhibit 10.17 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2000 filed on April 17, 2001

(7)

 

Incorporated by reference to Exhibit 10.18 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2000 filed on April 17, 2001

(8)

 

Incorporated by reference to Exhibit 10.18 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2002 filed on April 14, 2003

(9)

 

Incorporated by reference to Exhibit 10.19 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2002 filed on April 14, 2003

(10)

 

Incorporated by reference to Exhibit 10.17 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2003 filed on April 14, 2004

(11)

 

Incorporated by reference Exhibit 10.1 of the  Registrant’s Current Report on Form 8-K filed on September 16, 2004

(12)

 

Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 2004 filed on November 15, 2004

(13)

 

Incorporated by reference to Exhibit 14.1 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2004 filed on March 31, 2005

(14)

 

Incorporated by reference to Exhibit 4.1 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2005 filed on April 7, 2006

(15)

 

Incorporated by reference to Exhibit 10.16 of the Registrant’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 2007 filed on November 14, 2007

(16)

 

Incorporated by reference to Exhibit 10.17 of the Registrant’s Quarterly Report on Form 10-Q for the Three Months Ended June 30, 2008 filed on August 14, 2008

(17)

 

Incorporated by reference to Exhibit 3.1 of the Registrant’s Quarterly Report on Form 10-Q for the Three Months Ended September 30, 2008 filed on November 14, 2008

(18)

 

Incorporated by reference to Exhibit 3.2 of the Registrant’s Quarterly Report on Form 10-Q for the Three Months Ended September 30, 2008 filed on November 14, 2008

(19)

 

Incorporated by reference to Exhibit 10.18 of the Registrant’s Quarterly Report on Form 10-Q for the Three Months Ended September 30, 2008 filed on November 14, 2008

(20)

 

Incorporated by reference to Exhibit 10.19 of the Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 2009 filed on March 31, 2010

(21)

 

Incorporated by reference to Exhibit 10.19 of the Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 2011 filed on March 30, 2012

(22)

 

Incorporated by reference to Exhibit 10.20 of the Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 2011 filed on March 30, 2012

(23)

 

Incorporated by reference to Exhibit 10.21 of the Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 2014 filed on September 11, 2015

(24)

 

Incorporated by reference to Exhibit 10.22 of the Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 2014 filed on September 11, 2015











EX-31.1 2 nnup_ex31z1.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER Certification

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Michael A. Feinstein, M.D., Chief Executive Officer of Nocopi Technologies, Inc., certify that:

1.

I have reviewed this annual report on Form 10-K of Nocopi Technologies, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: March 30, 2016

/s/ Michael A. Feinstein, M.D.

Michael A. Feinstein, M.D.

Chief Executive Officer








EX-31.2 3 nnup_ex31z2.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER Certification

EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Rudolph A. Lutterschmidt, Vice President and Chief Financial Officer of Nocopi Technologies, Inc., certify that:

1.

I have reviewed this annual report on Form 10-K of Nocopi Technologies, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (registrant’s fourth fiscal quarter in the case of annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: March 30, 2016

/s/ Rudolph A. Lutterschmidt

Rudolph A. Lutterschmidt

Vice President and Chief Financial Officer







EX-32.1 4 nnup_ex32z1.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Certification

EXHIBIT 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Nocopi Technologies, Inc.  (the "Company") on Form 10-K for the Year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Michael A. Feinstein, M.D., Chief Executive Officer, and Rudolph A. Lutterschmidt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

(1)

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


/s/ Michael A. Feinstein, M.D.

Michael A. Feinstein, M.D.


/s/ Rudolph A. Lutterschmidt

Rudolph A. Lutterschmidt








EX-101.INS 5 nnup-20151231.xml XBRL INSTANCE FILE 0000888981 2014-01-01 2014-12-31 0000888981 2014-12-31 0000888981 2013-01-01 2013-12-31 0000888981 2012-01-01 2012-12-31 0000888981 2013-12-31 0000888981 us-gaap:CommonStockMember 2013-12-31 0000888981 us-gaap:CommonStockMember 2014-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000888981 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000888981 us-gaap:RetainedEarningsMember 2013-12-31 0000888981 us-gaap:RetainedEarningsMember 2014-12-31 0000888981 2015-12-31 0000888981 us-gaap:WarrantMember 2014-01-01 2014-12-31 0000888981 us-gaap:WarrantMember 2015-12-31 0000888981 us-gaap:SalesRevenueNetMember nnup:CustomerAMember 2014-01-01 2014-12-31 0000888981 us-gaap:SalesRevenueNetMember nnup:CustomerBMember 2014-01-01 2014-12-31 0000888981 us-gaap:AccountsReceivableMember nnup:CustomerAMember 2014-01-01 2014-12-31 0000888981 us-gaap:AccountsReceivableMember nnup:CustomerBMember 2014-01-01 2014-12-31 0000888981 us-gaap:NorthAmericaMember 2014-01-01 2014-12-31 0000888981 us-gaap:AsiaMember 2014-01-01 2014-12-31 0000888981 us-gaap:SalesRevenueNetMember nnup:CustomerAMember 2015-01-01 2015-12-31 0000888981 us-gaap:SalesRevenueNetMember nnup:CustomerBMember 2015-01-01 2015-12-31 0000888981 2016-03-15 0000888981 us-gaap:LoansPayableMember 2015-01-01 2015-12-31 0000888981 us-gaap:LoansPayableMember 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtOneMember 2015-01-01 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtOneMember 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtOneMember 2014-01-01 2014-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtTwoMember 2015-01-01 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtTwoMember 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtThreeMember 2015-01-01 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebtThreeMember 2015-12-31 0000888981 us-gaap:WarrantMember 2014-12-31 0000888981 us-gaap:MaximumMember 2015-01-01 2015-12-31 0000888981 us-gaap:MinimumMember 2015-01-01 2015-12-31 0000888981 nnup:EmploymentAgreementMember us-gaap:ChiefExecutiveOfficerMember 2015-01-01 2015-12-31 0000888981 nnup:EmploymentAgreementMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000888981 nnup:EmploymentAgreementMember us-gaap:ChiefOperatingOfficerMember 2015-01-01 2015-12-31 0000888981 nnup:EmploymentAgreementMember us-gaap:ChiefOperatingOfficerMember 2015-12-31 0000888981 nnup:EmploymentAgreementMember 2015-12-31 0000888981 us-gaap:AccountsReceivableMember nnup:CustomerAMember 2015-01-01 2015-12-31 0000888981 us-gaap:AccountsReceivableMember nnup:CustomerBMember 2015-01-01 2015-12-31 0000888981 us-gaap:NorthAmericaMember 2015-01-01 2015-12-31 0000888981 us-gaap:AsiaMember 2015-01-01 2015-12-31 0000888981 2015-06-30 0000888981 us-gaap:WarrantMember 2013-12-31 0000888981 2007-01-01 2007-12-31 0000888981 2015-01-01 2015-12-31 0000888981 us-gaap:CommonStockMember 2015-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0000888981 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000888981 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0000888981 us-gaap:RetainedEarningsMember 2015-12-31 0000888981 us-gaap:LineOfCreditMember 2008-12-31 0000888981 us-gaap:LineOfCreditMember 2008-01-01 2008-12-31 0000888981 us-gaap:LineOfCreditMember 2009-12-31 0000888981 us-gaap:LineOfCreditMember 2010-07-01 2010-09-30 0000888981 us-gaap:LineOfCreditMember 2014-07-01 2014-07-31 0000888981 us-gaap:WarrantMember 2015-01-01 2015-12-31 0000888981 us-gaap:LoansPayableMember 2014-12-31 0000888981 us-gaap:LoansPayableMember 2014-01-01 2014-12-31 0000888981 country:AU 2015-01-01 2015-12-31 0000888981 country:AU 2014-01-01 2014-12-31 0000888981 us-gaap:SubsequentEventMember 2016-03-01 2016-03-31 0000888981 us-gaap:ConvertibleDebtMember 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember 2015-01-01 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember 2015-07-01 2015-07-31 0000888981 us-gaap:ConvertibleDebtMember 2015-07-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebenturesDueThirdQuarter2017Member 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebenturesDueThirdQuarter2016Member 2015-12-31 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebenturesDueThirdQuarter2017Member 2015-07-01 2015-09-30 0000888981 us-gaap:ConvertibleDebtMember nnup:ConvertibleDebenturesDueThirdQuarter2017Member 2015-09-30 0000888981 us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000888981 us-gaap:ChiefExecutiveOfficerMember 2014-12-31 0000888981 us-gaap:ChiefExecutiveOfficerMember 2014-01-01 2014-12-31 0000888981 us-gaap:ChiefExecutiveOfficerMember 2015-01-01 2015-12-31 0000888981 us-gaap:ChiefExecutiveOfficerMember 2015-12-01 2015-12-31 0000888981 us-gaap:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember 2016-01-01 2016-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 2015 FY No No Yes .47 .19 .46 .35 .53 .17 .31 .25 922800 477100 445700 433000 511600 950800 6200 58599016 28000 52900 11400 287800 253300 43500 36600 18800 22600 378100 323900 19700 19700 176800 176900 196500 196600 178400 175700 18100 20900 396200 344800 63000 23500 102900 32800 160300 76200 383000 443000 93400 112400 802600 687900 31800 95000 586000 586000 12408500 12426600 -13432700 -13450700 -438200 -447800 586000 586000 12406600 12408500 -13440400 -13432700 -438100 586000 12426600 -13450700 396200 344800 5000 5000 1400 18100 1.00 1.00 300000 300000 0 0 0 0 0.01 0.01 75000000 75000000 58599016 58599016 58599016 58599016 58599016 58599016 58599016 358800 338700 564000 612100 75600 77000 248700 256000 324300 333000 598500 617800 121600 128100 194500 202800 253400 325600 569500 656500 29000 -12900 -143800 -38700 56300 300 21600 3100 4600 35600 -21300 20700 7700 10300 7700 386000 -18000 -18000 0.00 0.00 0.00 0.00 58599016 58599016 58600690 58599016 1900 1900 4000 6100 4600 21200 16300 -47000 50700 -34500 15000 -6900 -12700 3800 71600 32200 -20400 19000 1800 -88800 14500 41800 20600 8900 -20600 -8900 18800 5000 39500 39500 5000 4000 5000 105000 -18800 -49500 -24900 -16600 300 7700 -82900 -8800 72500 10400 8800 -24500 -3800 26400 1900 1674 0 23500 105000 28300 5000 63000 127800 .08 0.07 0.07 0.08 0.07 0.07 0.07 Forty-eight equal monthly installments 525000 141365 25000 .02 .02 0.02 0.02 P7Y P7Y P7Y P7Y During third quarter 2013 During third quarter 2014 During third quarter 2014 Two years from date of issuance Two years from date of issuance extended for two years 0.05 .05 0.025 0.05 0.025 P2Y P2Y P2Y P2Y 4601000 4627000 2035-12-31 1933000 1943000 2015 2011 46200 47400 48600 16300 44800 45100 160000 54200 2017-05 2017-03 85000 75000 .07 245000 -245000 0.12 519000 2021-07 756365 802365 660500 166365 0 -24500 -46000 0.022 0.025 0.026 0.02 0.037 0.068 590000 0.023 0.02 0.03 0.06 0.07 0.07 0.07 0.07 0.07 0.01 0.01 0.01 424500 364000 NOCOPI TECHNOLOGIES INC/MD/ 0000888981 --12-31 Smaller Reporting Company 10-K 2015-12-31 false 0.0375 0.0050 100000 2083 2010-10-01 6250 2019-12-31 Black-Scholes option pricing model 2000000 5846989 128300 5090624 18100 18100 10000 10000 6300 32800 32800 95000 95000 0.12 P0Y P4Y6M4D P4Y2M23D 0.01 0.07 <p style="margin: 0px"></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>1.</b></p> <p style="margin: 0px; text-indent: -2px; text-align: justify"><b>Organization of the Company</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">Nocopi Technologies, Inc. (the &#147;Company&#148;) is organized under the laws of the State of Maryland. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the Entertainment and Toy and the Document and Product Authentication markets in the United States and foreign countries. The Company operates in one principal industry segment.</p> <p style="margin: 0px"><br /></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>2.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Significant Accounting Policies</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify"><b>Financial Statement Presentation - </b>Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Estimates</b> - The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Cash </b>consists of demand deposits with a major U.S. bank.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Accounts receivable and credit policies </b>- Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Inventory </b>consists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or market.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Fixed assets</b> are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Patent costs </b>are charged to expense as incurred due to the uncertainty of their recoverability as a result of the Company&#146;s adverse liquidity situation.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Revenues</b> - In accordance with Financial Accounting Standards Board Accounting Standards Codification (&#147;FASB ASC&#148;) 605, Revenue Recognition<i>,</i> the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to these criteria, the Company will generally recognize revenue upon shipment of product. Revenue from license fees and royalties will be recognized as earned over the license term.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Income taxes</b> - Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Fair value</b> - The carrying amounts reflected in the balance sheets for cash, receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. The carrying amount of the demand loans and the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Convertible debentures</b>, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Stock-based payments</b> - the Company accounts for stock-based compensation under the provisions of FASB ASC 718, &#34;Compensation - Stock Compensation&#34; which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, &#34;Equity-Based Payments to Non-Employees (&#147;ASC 505-50&#148;). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders&#146; equity over the applicable service periods. Non-employee equity based payments that do not vest immediately upon grant are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Earnings (loss) per share</b> - The Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share.<font style="color: #FF0000"><b>&#160;</b></font>Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The table below presents the computation of basic and diluted weighted average common shares outstanding:</p> <p style="margin: 0px; text-align: justify"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: bottom"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: bottom; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom"><p style="margin: 0px">Basic shares outstanding</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">Incremental shares from assumed conversion of warrants</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">&#150;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">1,674</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom"><p style="margin: 0px">Diluted shares outstanding</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,600,690</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Comprehensive income (loss)</b> - The Company follows FASB ASC 220 in reporting comprehensive income.&#160;&#160;Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.&#160;&#160;Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net income (loss).</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px"><b>Recoverability of Long-Lived Assets</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company follows FASB ASC 360-35, &#147;Impairment or Disposal of Long-Lived Assets.&#148; The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.&#160; The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company&#146;s annual financial statements.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Recently Adopted Accounting Pronouncements</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">As of December 31, 2015 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company&#146;s financial statements.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px"><b>Recently Issued Accounting Pronouncements Not Yet Adopted</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">In August 2014, the FASB issued ASU 2014-15, <i>Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity&#146;s Ability to Continue as a Going Concern. </i>The amendments in this Update provide guidance about management&#146;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#146;s ability to continue as a going concern within one year after the date that the financial statements are issued and to provide related footnote disclosures. Substantial doubt about an entity&#146;s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management is assessing the impact of the adoption to the financial statements.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>3.</b></p> <p style="margin: 0px; text-indent: -2px; text-align: justify"><b>Going Concern</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">Since its inception, with the exception of the years ended December 31, 2007 and December&#160;31,&#160;2013 and December 13, 2014, during which it generated net income of $386,000 and $10,300 and $7,700, respectively, the Company has incurred significant losses and, as of December&#160;31,&#160;2015, had accumulated losses of $13,450,700. For the year ended December&#160;31,&#160;2015, the Company had a net loss from operations of $38,700. For the year ended December&#160;31,&#160;2014 Company&#146;s had net income from operations of $29,000. The Company had negative working capital of $364,000 at December 31,&#160;2015 and $424,500 at December 31, 2014. Due in part to uncertainties in the US economy, the Company, which is substantially dependent on its licensees to generate licensing revenues, may incur further operating losses and experience negative cash flow in the future. Achieving profitability and positive cash flow depends on the Company&#146;s ability to generate and sustain significant increases in revenues and gross profits from its traditional business. There can be no assurances that the Company will be able to generate sufficient revenues and gross profits to sustain profitability and return to positive cash flow in the future.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">During 2014, the Company sold a $5,000 convertible debenture to an investor. Receipt of funds in earlier periods from investors and from demand loan holders have allowed the Company to remain in operation through the current date. Management of the Company believes that it may need additional capital in the future both to fund investments needed to increase its operating revenues to levels that will sustain its operations and to fund operating deficits that it anticipates will continue until revenue increases from traditional and new product lines can be realized. There can be no assurances that the Company will be successful in obtaining sufficient additional capital, or if it does, that the additional capital will enable the Company to impact its revenues so as to have a material positive effect on the Company&#146;s operations and cash flow. The Company believes that without additional capital, whether in the form of debt, equity or both, it may be forced to cease operations at an undetermined future date.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company&#146;s independent registered public accountants have included a &#147;going concern&#148; explanatory paragraph in their audit report accompanying the 2015 financial statements. The paragraph states that the Company&#146;s continuing working capital deficit raises substantial doubt about the Company&#146;s ability to continue as a going concern and cautions that the financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>4</b>.</p> <p style="margin: 0px; text-indent: -2px; text-align: justify"><b>Concentration of Credit Risk</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">Certain financial instruments potentially subject the Company to concentrations of credit risk.&#160; These financial instruments consist primarily of cash and accounts receivables. At December&#160;31,&#160;2015, the Company did not have deposits with a financial institution that exceed the FDIC deposit insurance coverage of $250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>5.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Demand Loans</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">At December 31, 2015 and December 31, 2014 the Company had unsecured loans totaling $23,500 from two individuals and $63,000 from three individuals, respectively, outstanding. The loans bear interest at 8%. During the year ended December 31, 2015, the Company repaid $39,500 of the unsecured loans along with approximately $6,300 of accrued interest. During the year ended December 31, 2014, the Company repaid $5,000 of the unsecured loans.</p> <p style="margin: 0px"></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>6.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Promissory Note</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">In early July 2014, the Company repaid the $6,250 remaining balance of a $100,000 promissory note with a bank. The promissory note resulted from the conversion in September 2010 of an outstanding line of credit with the bank. The promissory note was payable in forty-eight equal monthly installments, beginning in October 2010, of $2,083, plus interest at the bank&#146;s prime rate of interest plus 0.5%. The interest rate throughout the term of the promissory note was 3.75%.</p> <p style="margin: 0px"><br /></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>8.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Stockholders' Deficiency</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">In July 2015, the common stock private placement was extended to December 31, 2016 by the Company&#146;s Board of Directors.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>9.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Other Income (Expenses)</b></p> <p style="margin: 0px; clear: left; text-align: justify"><br /></p> <p style="margin: 0px; text-align: justify">Other income (expenses) includes, in 2015, the reversal of approximately $56,300 of accounts payable related to invoices received from 2001 through 2009 from a professional services business that provided legal services to the Company and an individual that provided consulting services to the Company in 2009 that the Company, with legal counsel, has determined to be no longer statutorily payable as the statute of limitations to bring claims has expired. Additionally, other income (expenses) includes interest on unsecured loans from five individuals, on convertible debentures held by ten investors and, in 2014, on funds borrowed under the Company&#146;s promissory note with a bank. Also included in other income (expenses) is accretion of debt discounts related to the issuance of convertible debentures totaling $128,400 and, in 2015, the extension of the maturity dates of $95,000 of convertible debentures.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>10.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Income Taxes</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">There is no income tax benefit for the year ended December 31, 2015 due to the availability of net operating loss carryforwards (&#147;NOL&#146;s&#148;) for which the Company had previously established a 100% valuation allowance for deferred tax assets due to the uncertainty of their recoverability. There is no provision for income taxes for the year ended December 31,&#160;2014 due to the availability of net operating loss carryforwards. At December 31, 2015 and December&#160;31,&#160;2014, the Company had NOL&#146;s approximating $4,627,000 and $4,601,000, respectively. The operating losses at December&#160;31,&#160;2015 are available to offset future taxable income; however, if not utilized, they expire in varying amounts through the year 2035. As a result of the sale of the Company's common stock in an equity offering in late 1997 and the issuance of additional shares, the amount of the NOL&#146;s may be limited. Additionally, the utilization of these NOL&#146;s, if available, to reduce future income taxes will depend on the generation of sufficient taxable income prior to their expiration. There were no material temporary differences for the years ended December&#160;31,&#160;2015 and December 31, 2014. The Company has established a 100% valuation allowance of approximately $1,943,000 and $1,933,000 at December 31, 2015 and December&#160;31,&#160;2014, respectively, for the deferred tax assets due to the uncertainty of their realization.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company has adopted the provisions of FASB ASC 740-10-50-15, &#147;Unrecognized Tax Benefit Related Disclosures.&#148; There were no unrecognized tax benefits as of the date of adoption and no unrecognized tax benefits at December&#160;31, 2015. There was no change in unrecognized tax benefits during the year ended December&#160;31,&#160;2015 and there was no accrual for uncertain tax positions as of December 31, 2015.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">There were no interest and penalties recognized in the statement of operations and in the balance sheet. Tax years from 2011 through 2015 remain subject to examination by U.S. federal and state tax jurisdictions.</p> <p style="margin: 0px; clear: left"></p> <p style="margin: 0px; text-align: justify"><b>Financial Statement Presentation - </b>Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Estimates</b> - The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.</p> <p style="margin: 0px; text-align: justify"><b>Cash </b>consists of demand deposits with a major U.S. bank.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Accounts receivable and credit policies </b>- Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.</p> <p style="margin: 0px; text-align: justify"><b>Inventory </b>consists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or market.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Fixed assets</b> are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.</p> <p style="margin: 0px; text-align: justify"><b>Patent costs </b>are charged to expense as incurred due to the uncertainty of their recoverability as a result of the Company&#146;s adverse liquidity situation.</p> <p style="margin: 0px; text-align: justify"><b>Revenues</b> - In accordance with Financial Accounting Standards Board Accounting Standards Codification (&#147;FASB ASC&#148;) 605, Revenue Recognition<i>,</i> the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to these criteria, the Company will generally recognize revenue upon shipment of product. Revenue from license fees and royalties will be recognized as earned over the license term.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Income taxes</b> - Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="margin: 0px; text-align: justify"><b>Fair value</b> - The carrying amounts reflected in the balance sheets for cash, receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. The carrying amount of the demand loans and the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Convertible debentures</b>, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Stock-based payments</b> - the Company accounts for stock-based compensation under the provisions of FASB ASC 718, &#34;Compensation - Stock Compensation&#34; which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, &#34;Equity-Based Payments to Non-Employees (&#147;ASC 505-50&#148;). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders&#146; equity over the applicable service periods. Non-employee equity based payments that do not vest immediately upon grant are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Earnings (loss) per share</b> - The Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share.<font style="color: #FF0000"><b>&#160;</b></font>Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The table below presents the computation of basic and diluted weighted average common shares outstanding:</p> <p style="margin: 0px; text-align: justify"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: bottom"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: bottom; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom"><p style="margin: 0px">Basic shares outstanding</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">Incremental shares from assumed conversion of warrants</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">&#150;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">1,674</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom"><p style="margin: 0px">Diluted shares outstanding</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,600,690</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify"><b>Comprehensive income (loss)</b> - The Company follows FASB ASC 220 in reporting comprehensive income.&#160;&#160;Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.&#160;&#160;Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net income (loss).</p> <p style="margin: 0px"><b>Recoverability of Long-Lived Assets</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company follows FASB ASC 360-35, &#147;Impairment or Disposal of Long-Lived Assets.&#148; The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.&#160; The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company&#146;s annual financial statements.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify"><b>Recently Adopted Accounting Pronouncements</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">As of December 31, 2015 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company&#146;s financial statements.</p> <p style="margin: 0px"></p> <p style="margin: 0px"><b>Recently Issued Accounting Pronouncements Not Yet Adopted</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">In August 2014, the FASB issued ASU 2014-15, <i>Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity&#146;s Ability to Continue as a Going Concern. </i>The amendments in this Update provide guidance about management&#146;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#146;s ability to continue as a going concern within one year after the date that the financial statements are issued and to provide related footnote disclosures. Substantial doubt about an entity&#146;s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management is assessing the impact of the adoption to the financial statements.</p> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify">The table below presents the computation of basic and diluted weighted average common shares outstanding:</p> <p style="margin: 0px; text-align: justify"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: bottom"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: bottom; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom"><p style="margin: 0px">Basic shares outstanding</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">Incremental shares from assumed conversion of warrants</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">&#150;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">1,674</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom"><p style="margin: 0px">Diluted shares outstanding</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,599,016</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">58,600,690</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify">A summary of stock options under the Company&#146;s stock option plans follows:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.66px"></td><td style="width: 2.93px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 3.2px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Weighted</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Average</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Number of</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price Range</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Per Share</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2013</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">245,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Options expired</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">245,000</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2014 and 2015</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">0</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">&#150;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">&#150;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Option</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Exercisable options at year end:</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">2015</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">0</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Weighted average remaining contractual life (years)</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">&#150;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Options available for future grant:</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">2015</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">0</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px; text-align: justify">A summary of outstanding warrants follows:</p> <p style="margin: 0px; text-align: justify"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.66px"></td><td style="width: 2.93px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 3.2px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Weighted</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Average</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Number of</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price Range</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Per Share</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2013</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">660,500</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.01 to 0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.026</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Warrants granted</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">166,365</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.02</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.02</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Warrants canceled</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">24,500</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.03 and 0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.037</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2014</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">802,365</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.01 to 0.07</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.025</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Warrants expired</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; text-align: center">46,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.06 and 0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.068</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2015</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: top; width: 93px"><p style="margin: 0px; text-align: center">756,365</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">$0.01 to $0.07</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">$0.022</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Weighted average remaining contractual life (years)</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; text-align: center">4.51</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Weighted</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Average</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price Range</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Per Share</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Exercisable warrants at year end:</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">2015</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">590,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">$0.01 to $0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">$0.023</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Weighted average remaining contractual life (years)</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">4.23</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr></table> <p style="margin: 0px; clear: left"></p> <p style="margin: 0px; text-align: justify">The Company&#146;s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company&#146;s total revenues were:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 5.46px"></td><td style="width: 5.46px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td><td style="width: 5.53px"></td><td style="width: 5.53px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="6" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 145.93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Year ended December 31</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 64.6px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.53px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 64.66px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Customer A</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">53</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">47</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Customer B</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">17</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">19</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> </table> <p style="margin: 0px"></p> <p style="margin: 0px; text-align: justify">The Company&#146;s non-affiliate customers whose individual balances amounted to more than 10% of the Company&#146;s net accounts receivable, expressed as a percentage of net accounts receivable, were:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 5.46px"></td><td style="width: 5.46px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td><td style="width: 5.53px"></td><td style="width: 5.53px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="6" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 145.93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>December 31</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 64.6px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.53px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 64.66px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; text-align: justify">&#160;Customer A</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">31</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">46</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px; text-align: justify">&#160;Customer B</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">25</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">35</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> </table> <p style="margin: 0px; text-align: justify">The Company&#146;s revenues by geographic region are as follows:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="6" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 147.86px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Year ended December 31</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; text-align: justify">North America</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">433,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">477,100</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; text-align: justify">Asia</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">511,600</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">445,700</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; text-align: justify">Australia</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">6,200</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">&#150;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">950,800</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">922,800</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> 18100 Black-Scholes pricing model 24500 4500 3800 128400 95000 85000 85000 290400 215400 10000 15000 <p style="margin: 0px"></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>7.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Convertible Debentures</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">At December 31, 2015, the Company had convertible debentures totaling $127,800 outstanding, of which $32,800 are due during the third quarter of 2016 and $95,000 are due during the third quarter of 2017. The convertible debentures bear interest at 7%. At the option of the lender, $95,000 principal of the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.025 per share and $32,800 principal of the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. In July 2015, the Company repaid, with interest, a $10,000 convertible debenture that had matured. During the third quarter of 2015, the Company&#146;s Board of Directors approved and the holders of $95,000 of convertible debentures maturing during the third quarter of 2015 accepted an offer of extension whereby the maturity dates of the convertible debentures are extended for two years and the conversion rate of the debentures and accrued interest into Common Stock of the Company is reduced from $0.05 to $0.025. In accordance with FASB ASC 470, this modification of the convertible debentures was recorded as a debt discount to the notes payable of approximately $18,100 with an offsetting credit to additional-paid in capital. In the year ended December 31, 2015, the entire $18,100 was accreted through interest expense.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">During the third quarter of 2014, the Company, with the approval of its Board of Directors, exchanged two demand loans totaling $24,500 including one demand loan in the amount of $4,500 held by Herman M. Gerwitz, a Director, along with approximately $3,800 of accrued interest for convertible debentures totaling approximately $28,300. The debentures bear interest at 7% and are due and payable two years from the date of issuance. At option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 141,365 shares of common stock of the Company at $0.02 per share to the debenture holders. The warrants are exercisable two years after issuance and expire seven years after issuance.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">During the third quarter of 2014, the Company received $5,000 through the issuance of a convertible debenture to an investor. The debenture bears interest at 7% and is due and payable two years from the date of issuance. At option of the lender, the debenture and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 25,000 shares of the Company&#146;s common stock at $0.02 per share to the holder of the debenture. The warrants are exercisable two years after issuance and expire seven years after issuance.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">Additionally, the Company has warrants to purchase 525,000 shares of the Company&#146;s common stock at $0.02 per share outstanding that were granted in conjunction with the issuance of $105,000 of convertible debentures to seven investors in 2013. The warrants are exercisable two years after issuance and expire seven years after issuance.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since the Company determined that the warrants were an equity instrument in accordance with FASB&#160;ASC&#160;815. The debt discount related to the warrant issuances is being accreted through interest expense over the term of the notes payable. For the years ended December 31, 2015 and December 31, 2014, approximately $3,100 and $4,600, respectively, was accreted through interest expense.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>11.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Related Party Transactions</b></p> <p style="margin: 0px; clear: left; text-align: justify"><br /></p> <p style="margin: 0px; text-align: justify">In each of the years ended December 31, 2015 and December 31, 2014, Michael&#160;A.&#160;Feinstein,&#160;M.D., the Company&#146;s Chairman of the Board and Chief Executive Officer, deferred $85,000 of salary owed to him under an employment agreement with the Company. At December 31, 2015 and December 31, 2014, Dr. Feinstein was owed $290,400 and $215,400, respectively, of salary that was deferred by him in response to the adverse liquidity experienced by the Company beginning in 2012. There are no formal terms or arrangements for repayment of the deferred salary. In December 2015 and January 2016, the Company made payments of $10,000 and $15,000, respectively, to Dr. Feinstein, representing a portion of amounts owed to him. There is no interest payable on the deferred salary. &#160;</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>12.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Commitments and Contingencies</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">The Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2019.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at December&#160;31,&#160;2015 are: $46,200 &#150; 2016; $47,400 &#150; 2017; $48,600 &#150; 2018 and $16,300 &#150; 2019.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">Total rental expense under operating leases was $44,800 and $45,100 in 2014 and 2015, respectively.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company has an employment agreement, expiring in May 2017, with Michael&#160;A.&#160;Feinstein,&#160;M.D., its Chairman of the Board and Chief Executive Officer. The employment agreement contains one-year renewal provisions that became effective after the original term. Dr. Feinstein receives base compensation of $85,000 per year plus a performance bonus determined by the Company&#146;s Board of Directors. The Company has an employment agreement, expiring in March 2017, with Terry W. Stovold, its Chief Operating Officer, whereby Mr.&#160;Stovold receives a salary set by the Company&#146;s Board of Directors, currently set at $75,000, along with a commission of seven percent on sales generated by his efforts. The employment agreement contains one-year renewal provisions that became effective after the original term. Future minimum compensation payments under these employment agreements are: $160,000&#160;to be paid in&#160;2016 and $54,200&#160;to be paid in&#160;2017.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">From time to time, the Company may be subject to legal proceedings and claims that arise in the ordinary course of its business.</p> <p style="margin: 0px"></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>13.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Stock Options, Warrants and 401(k) Savings Plan</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">The Company follows FASB ASC 718,<i> Share Based Payment, </i>which requires that the cost resulting from all share-based payment transactions be recognized in the Company&#146;s financial statements. FASB ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The 1999 Stock Option Plan provided for the granting of up to 2,000,000 incentive and non-qualified stock options to employees, non-employee directors, consultants and advisors to the Company. In the case of options designated as incentive stock options, the exercise price of the options granted must be not less than the fair market value of such shares on the date of grant. Non-qualified stock options may be granted at any amount established by the Stock Option Committee or, in the case of Discounted Options issued to non-employee directors in lieu of any portion of an Annual Retainer, in accordance with a formula designated in the Plan. The 1999 Stock Option Plan terminated in February 2009 and no further stock options can be granted under the plan; however, options granted before the termination date could be exercised through their expiration date.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-indent: -2px; text-align: justify">The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no compensation expense recognized during the years ended December&#160;31,&#160;2015 and December 31, 2014 and there was no unrecognized portion of expense at December&#160;31,&#160;2015.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">A summary of stock options under the Company&#146;s stock option plans follows:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.66px"></td><td style="width: 2.93px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 3.2px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Weighted</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Average</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Number of</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price Range</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Per Share</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2013</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">245,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Options expired</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">245,000</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.12</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2014 and 2015</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 3px double; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">0</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">&#150;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">&#150;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Option</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Exercisable options at year end:</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">2015</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">0</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Weighted average remaining contractual life (years)</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">&#150;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Options available for future grant:</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">2015</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">0</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">At December 31, 2015, the Company had 756,365 warrants to purchase common stock of the Company outstanding at exercise prices ranging from $0.01 to $0.07 and expiring at various dates through July 2021. The warrants are held by ten investors who acquired convertible debentures from the Company in 2013 and 2014 and by three individuals who provided loans and professional services to the Company. </p> <p style="margin: 0px; text-align: justify"><br /></p> <p style="margin: 0px; text-align: justify">A summary of outstanding warrants follows:</p> <p style="margin: 0px; text-align: justify"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.66px"></td><td style="width: 2.93px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 3.2px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 90.06px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Weighted</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Average</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Number of</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price Range</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93.26px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Per Share</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 96.8px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2013</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">660,500</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.01 to 0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.026</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Warrants granted</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">166,365</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.02</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.02</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Warrants canceled</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">24,500</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.03 and 0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.037</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2014</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">802,365</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.01 to 0.07</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.025</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Warrants expired</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; text-align: center">46,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">0.06 and 0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">0.068</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Outstanding at December 31, 2015</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: top; width: 93px"><p style="margin: 0px; text-align: center">756,365</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">$0.01 to $0.07</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">$0.022</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Weighted average remaining contractual life (years)</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; text-align: center">4.51</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Weighted</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Average</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 93px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price Range</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Exercise</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Shares</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Per Share</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td><td style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 90.06px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Price</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px; font-size: 8pt">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">Exercisable warrants at year end:</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; padding-left: 24px; text-indent: -8px">2015</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">590,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93.26px"><p style="margin: 0px; text-align: center">$0.01 to $0.07</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 96.8px"><p style="margin: 0px; text-align: center">$0.023</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 2.93px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Weighted average remaining contractual life (years)</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.66px"><p style="margin: 0px">&#160;</p> </td><td colspan="2" style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 93px"><p style="margin: 0px; text-align: center">4.23</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 3.2px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 90.06px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">At December 31, 2015, the Company has reserved 5,846,989 shares of common stock for possible future issuance upon exercise of 756,365 warrants and for the conversion of approximately $128,300 of convertible debentures and accrued interest into 5,090,624 shares of common stock.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of the Company. There were no contributions charged to expense during 2015 or 2014.</p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>14.</b></p> <p style="margin: 0px; text-indent: -2px; text-align: justify"><b>Major Customer and Geographic Information</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">The Company&#146;s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company&#146;s total revenues were:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 5.46px"></td><td style="width: 5.46px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td><td style="width: 5.53px"></td><td style="width: 5.53px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="6" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 145.93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Year ended December 31</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 64.6px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.53px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 64.66px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px">Customer A</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">53</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">47</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px">Customer B</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">17</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">19</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> </table> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company&#146;s non-affiliate customers whose individual balances amounted to more than 10% of the Company&#146;s net accounts receivable, expressed as a percentage of net accounts receivable, were:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 5.46px"></td><td style="width: 5.46px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td><td style="width: 5.53px"></td><td style="width: 5.53px"></td><td style="width: 59.13px"></td><td style="width: 11.13px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="6" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 145.93px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>December 31</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.46px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 64.6px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 5.53px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 64.66px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 11.13px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; text-align: justify">&#160;Customer A</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">31</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">46</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> <tr><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: top"><p style="margin: 0px; text-align: justify">&#160;Customer B</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.46px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">25</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 5.53px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 59.13px"><p style="margin: 0px; text-align: right">35</p> </td><td style="margin-top: 0px; background-color: #FFFFFF; vertical-align: bottom; width: 11.13px"><p style="margin: 0px">%</p> </td></tr> </table> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on the Company&#146;s business operations and financial condition.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; text-align: justify">The Company&#146;s revenues by geographic region are as follows:</p> <p style="margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" style="margin-top: 0px; font-size: 10pt; width: 100%"><tr style="height: 0px; font-size: 0"><td></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 6.73px"></td><td style="width: 60.46px"></td><td style="width: 6.73px"></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="6" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 147.86px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>Year ended December 31</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2015</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td><td colspan="2" style="margin-top: 0px; border-bottom: #000000 1px solid; vertical-align: top; width: 67.2px"><p style="margin: 0px; font-size: 8pt; text-align: center"><b>2014</b></p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; font-size: 8pt"><b>&#160;</b></p> </td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; text-align: justify">North America</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-top: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">433,000</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">477,100</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px; text-align: justify">Asia</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">511,600</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">445,700</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: top"><p style="margin: 0px; text-align: justify">Australia</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">6,200</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #000000 1px solid; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">&#150;</p> </td><td style="margin-top: 0px; background-color: #CCFFCC; border-bottom: #FFFFFF 1px solid; vertical-align: bottom; width: 6.73px"><p style="margin: 0px; padding: 0px">&#160;</p></td></tr> <tr><td style="margin-top: 0px; vertical-align: top"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">950,800</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">$</p> </td><td style="margin-top: 0px; border-bottom: #000000 3px double; vertical-align: bottom; width: 60.46px"><p style="margin: 0px; text-align: right">922,800</p> </td><td style="margin-top: 0px; border-bottom: #FFFFFF 3px double; vertical-align: bottom; width: 6.73px"><p style="margin: 0px">&#160;</p> </td></tr> </table> <p style="margin: 0px"></p> <p style="margin-top: 0px; margin-bottom: -2px; width: 48px; float: left"><b>15.</b></p> <p style="margin: 0px; text-indent: -2px"><b>Subsequent Event</b></p> <p style="margin: 0px; clear: left"><br /></p> <p style="margin: 0px; text-align: justify">In March 2016, the Company repaid $4,000 of the principal of the outstanding demand loans.</p> EX-101.SCH 6 nnup-20151231.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statement of Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization of the Company link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Demand Loans link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Promissory Note link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Convertible Debentures link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders' Deficiency link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Other Income (Expenses) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Major Customer and Geographic Information link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Quarterly Financial Information (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Major Customer and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Quarterly Financial Information (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Significant Accounting Policies (Schedule of Basic and Diluted Weighted Average Common Shares Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Going Concern (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Concentration of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Demand Loans (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Promissory Note (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Convertible Debentures (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Other Income (Expenses) (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Commitments and Contingencies (Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Commitments and Contingencies (Employment Agreements) (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Summary of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Summary of Warrants Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Stock Options and Warrants (Summary of Warrants Outstanding by Price Range) (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nnup-20151231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 nnup-20151231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 nnup-20151231_lab.xml XBRL LABEL FILE Common stock [Member] Statement Equity Components [Axis] Paid-in Capital [Member] Accumulated Deficit [Member] Stock Option Exercise Range One [Member] Exercise Price Range [Axis] Warrant [Member] Award Type [Axis] Warrant Exercise Price Range One [Member] Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options By Exercise Price Range [Axis] Revenue [Member] Concentration Risk Type [Axis] Customer A [Member] Concentration Risk Type [Axis] Customer B [Member] Customer C [Member] Accounts Receivable [Member] North America [Member] Geographical [Axis] Asia [Member] South America [Member] Europe [Member] Quarterly Information [Member] Quarterly Information [Axis] Unsecured Loan [Member] Short-term Debt, Type [Axis] Unsecured Loan One [Member] Short-term Debt, Type [Axis] Unsecured Loan Two [Member] Unsecured Loan Three [Member] Unsecured Loan Four [Member] Unsecured Loan Five [Member] Unsecured Loan Six [Member] Unsecured Loan Seven [Member] Unsecured Loan Eight [Member] Unsecured Loan Nine [Member] Convertible Debt [Member] Long-term Debt, Type [Axis] Convertible Debt Issued to Seven Investors during 2013 [Member] Convertible Debt Exchanged For Two Demand Loans [Member] Convertible Debt Issued to Investor During Third Quarter 2014 [Member] Director [Member] Statement Equity Components [Axis] Restricted Common Stock [Member] Maximum [Member] Range [Axis] Minimum [Member] Employment Agreement [Member] Other Commitments [Axis] Chief Executive Officer [Member] Chief Operating Officer [Member] Revolving Line of Credit [Member] Australia [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Convertible Debt Due Third Quarter 2017 [Member] Convertible Debt Due Third Quarter 2016 [Member] Related Party [Axis] Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Entity Public Float Entity Common Stock Shares Outstanding Entity Well Known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Statement of Financial Position [Abstract] Assets Current assets Cash Accounts receivable less $5,000 allowance for doubtful accounts Inventory Prepaid and other Total current assets Fixed assets Leasehold improvements Furniture, fixtures and equipment Fixed assets, gross Less: accumulated depreciation and amortization Total fixed assets Total assets Liabilities and Stockholders' Deficiency Current liabilities Demand loans Convertible debentures Accounts payable Accrued expenses Deferred revenue Total current liabilities Commitments and contingencies Convertible debentures, net of unaccreted discount of $0 at December 31, 2015 and $1,400 at December 31, 2014 Stockholders' deficiency Series A preferred stock, $1.00 par value, Authorized - 300,000 shares, Issued and outstanding - none Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 58,599,016 shares Paid-in capital Accumulated deficit Total stockholders' deficiency Total liabilities and stockholders' deficiency Allowance for doubtful accounts Unaccreted discount on convertible debentures Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Licenses, royalties and fees Product and other sales Total revenues Cost of revenues Licenses, royalties and fees Product and other sales Total cost of revenues Gross profit Operating expenses Research and development Sales and marketing General and administrative Total operating expenses Net income (loss) from operations Other income (expenses) Reversal of accounts payable Interest income Interest expense, bank charges, financing cost and accretion of interest Total other income (expenses) Net income (loss) Net income (loss) per common share Basic Diluted Weighted average common shares outstanding Basic Diluted Statement [Table] Statement [Line Items] Equity Components [Axis] Balance Balance, shares Sales of common stock, value Sales of common stock, shares Conversion of demand notes and interest, value Conversion of demand notes and interest, shares Fair value of warrants issued to demand loan holders Fair value of warrants issued to convertible debenture holders Debt discount to convertible debentures Net income (loss) Balance Balance, shares Statement of Cash Flows [Abstract] Operating Activities Adjustments to reconcile net income (loss) to net cash provided by operating activities Depreciation and amortization Reversal of accounts payable Accretion of interest - convertible debentures Net income (loss) adjusted for non-cash operating activities (Increase) decrease in assets Accounts receivable Inventory Prepaid and other Increase (decrease) in liabilities Accounts payable and accrued expenses Deferred revenue Total increase (decrease) in operating capital Net cash provided by operating activities Investing Activities Additions to fixed assets Net cash used in investing activities Financing Activities Repayment of borrowings under promissory note Repayment of demand loans Proceeds from convertible debentures Repayment of convertible debenture Net cash used in financing activities Decrease in cash Cash Beginning of year End of year Cash paid for interest Supplemental Disclosure of Non Cash Investing Activities Write-off of fully depreciated leasehold improvements and furniture fixtures and equipment Accumulated depreciation and amortization Leasehold improvements Furniture, fixtures and equipment Supplemental Disclosure of Non Cash Financing Activities Conversion of demand loans and interest to convertible debentures Demand loans Accrued expenses Convertible debentures Paid-in capital Conversion of demand loans and interest to common stock Demand loans Accrued expenses Common stock Paid-in capital Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization of the Company Accounting Policies [Abstract] Significant Accounting Policies Going Concern [Abstract] Going Concern Risks and Uncertainties [Abstract] Concentration of Credit Risk Debt Disclosure [Abstract] Demand Loans Line of Credit Facility [Abstract] Promissory Note Convertible Debt [Abstract] Convertible Debentures Stockholders' Equity Note [Abstract] Stockholders' Deficiency Other Income and Expenses [Abstract] Other Income (Expenses) Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock Options, Warrants and 401(k) Savings Plan Major Customer and Geographic Information [Abstract] Major Customer and Geographic Information Subsequent Events [Abstract] Subsequent Event Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information (Unaudited) Financial Statement Presentation Estimates Cash Accounts receivable and credit policies Inventory Fixed assets Patent costs Revenues Income taxes Fair value Convertible debentures Stock-based payments Earnings (loss) per share Comprehensive income (loss) Recoverability of Long-Lived Assets Recently Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Not Yet Adopted Schedule of Computation of Basic and Diluted Weighted Average Common Shares Outstanding Schedule of Stock Option Activity Schedule of Warrants Outstanding Segment Reporting [Abstract] Schedule of Revenues from Non-affiliated Customers Schedule of Non-affiliated Customers with Accounts Receivable More Than 10% Schedule of Revenue by Geographic Region Schedules of Quarterly Information Basic shares outstanding Incremental shares from assumed conversion of stock options and warrants Diluted shares outstanding Net loss (income) Accumulated deficit Working capital deficit Operating loss (income) Amount of cash unisured by FDIC Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Debt Instrument [Axis] Debt instrument, face amount Debt instrument, interest rate Debt instrument, issuance date Debt instrument, payment terms Repayments of demand loans Repayment of accrued interest Line of Credit Facility [Table] Line of Credit Facility [Line Items] Revolving line of credit, maximum borrowing capacity Revolving line of credit, interest rate Revolving line of credit, basis spread over prime rate Revolving line of credit, amount outstanding Amount of monthly installment payments of principal, plus interest to repay line of credit facility Re-payment terms of line of credit facility Revolving line of credit, required first payment date Repayment of line of credit Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt instrument, issuance date Debt instrument, maturity date Debt instrument, conversion price per share Convertible debt due during the third quarter of 2016 Convertible debt due during the third quarter of 2017 Number of shares of common stock that can be purchased through warrants Repayments of convertible debenture Price per share of warrants Warrant exercisable term Warrant expiration term Fair value of warrants issued Relative fair value of warrants recorded as discount to notes payable Pricing model used to value warrants Interest expense Number of warrants issued during period Debt discount recognized on notes payable Accretion of debt discount recognized as interest expense Value of demand loans exchanged for convertible debt Value of demand loans from Director exchanged for convertible debt Value of accrued interest on demand loans exchanged for convertible debt Total value of convertible debt that accretion of debt discounts was recognized during the period Additional value of convertible debt that accretion of debt discounts was recognized during the period Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Income tax provision Net operating loss carryforwards Net operating loss carryforwards, expiration date Deferred tax assets, valuation allowance Unrecognized tax benefits Change in unrecognized tax benefits during the period Accrual for uncertain tax positions Interest and penalties from tax examinations recognized in the statement of operations Interest and penalties from tax examinations recognized on the balance sheet Tax years open for examination Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Amount of salary deferred by related party Amount of deferred salary owed to related party Portions of deferred salary paid to related party Lease expiration date Future minimum payments due under operating leases: 2016 2017 2018 2019 2020 Total rent expense under operating lease agreement Other Commitments [Table] Other Commitments [Line Items] Related Party Transaction [Axis] Employment contract, expiration date Annual base compensation owed to employee per employment agreement Commission rate owed to employee expressed as percentage of sales Future minimum compensation payments due 2016 Future minimum compensation payments due 2017 Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of shares authorized under plan Method used to value the grant date fair value of awards Options granted during period Fair value assumptions, expected term Fair value assumptions, interest rate Fair value assumptions, volatility rate Fair value assumptions, dividend rate Compensation expense from options not yet recognized Shares remaining available for grant Employer contributions for 401(k) savings plan charged to expense during period Stock option compensation expense recognized Warrants expiration date Number of common shares reserved for possible future warrant issuance and debt conversion Value of outstanding convertible debentures and accrued interest that could be converted Number of common shares reserved for possible future debt conversion Number of Shares Options outstanding at beginning of period Granted Options exercised Options cancelled Options expired Options outstanding at end of period Options exercisable at end of period Weighted Average Exercise Price Options outstanding at beginning of period Options granted Options exercised Options cancelled Options expired Options outstanding at end of period Options exercisable at end of period Weighted average remaining contractual life Warrants Warrants outstanding at beginning of period Granted Exercised Cancelled/Expired Warrants outstanding at end of period Price Warrants outstanding at beginning of period Granted Exercised Cancelled/Expired Warrants outstanding at end of period Schedule Of Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options By Exercise Price Range [Table] Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options Exercise Price Range [Line Items] Warrants outstanding exercise price range, lower limit Warrants outstanding exercise price range, upper limit Warrants granted exercise price range, lower limit Warrants granted exercise price range, upper limit Warrants expired/cancelled exercise price range, lower limit Warrants expired/cancelled exercise price range, upper limit Warrants exercisable exercise price range, lower limit Warrants exercisable exercise price range, upper limit Weighted average remaining contractual life Number exercisable Weighted average exercise price, exercisable Warrants exercisable, weighted average remaining contractual life Schedule of Revenue by Major Customers, by Reporting Segments [Table] Revenue, Major Customer [Line Items] Concentration Risk Benchmark [Axis] Customer [Axis] Risk percentage Concentration Risk [Table] Concentration Risk [Line Items] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues Subsequent Event [Table] Subsequent Event [Line Items] Repayments of outstanding demand loans Conversion of demand loans and interest to common stock. The increase (decrease) during the reporting period in accrued expenses due to non-cash financing activities The increase (decrease) during the reporting period in common stock value due to non-cash financing activities The increase (decrease) during the reporting period in demand loans outstanding due to non cash financing activities The increase (decrease) during the reporting period in paid-in capital due to non-cash financing activities The accounting policy for patent costs. The accounting policy for recently issued accounting pronouncements not yet adopted. The amount that current liabilities exceed current assets. Stock Option Exercise Range One [Member] Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Roll Forward [Abstract] Weighted average price at which grantees can acquire the shares reserved for issuance for equity instruments other than options. Weighted average per share amount at which grantees can acquire shares of common stock by exercise of equity instruments other than options. Weighted average price at which holders acquired shares when converting equity instruments other than options into shares. Weighted average price at which grantees could have acquired the underlying shares with respect to equity instrument other than options that have expired. Schedule Of Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options By Exercise Price Range [Table] Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options Exercise Price Range [Line Items] Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options By Exercise Price Range [Axis] Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options Exercise Price Range [Domain] Warrant Exercise Price Range One [Member] Weighted average remaining contractual term of outstanding equity instruments other than options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. The number of shares reserved for issuance pertaining to the outstanding exercisable equity instruments other than options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Customer A [Member] Customer B [Member] Customer C [Member] The entire disclosure for promissory notes. The entire disclosure for convertible debentures. The value of accumulated depreciation and amortization from writedown of fully depreciated property, plant and equipment in noncash investing transactions. The value of writedown from cost of leasehold improvements from noncash investing transactions. The value of writedown from cost of furniture, fixtures and equipment from noncash investing transactions. Conversion of demand loans and interest to convertible debentures [Abstract] The increase (decrease) during the reporting period in demand loans outstanding due to conversion of demand loans and interest to convertible debentures in non cash financing activities. The increase (decrease) during the reporting period in accrued expenses due to conversion of demand loans and interest to convertible debentures in non cash financing activities. The increase (decrease) during the reporting period in convertible debentures due to conversion of demand loans and interest to convertible debentures in non cash financing activities. The increase (decrease) during the reporting period in additional paid-in capital due to conversion of demand loans and interest to convertible debentures in non cash financing activities. Expiration term of warrant, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Unsecured Loan One [Member] Unsecured Loan Two [Member] Unsecured Loan Three [Member] Unsecured Loan Four [Member] Unsecured Loan Five [Member] Unsecured Loan Six [Member] Unsecured Loan Seven [Member] Unsecured Loan Eight [Member] Unsecured Loan Nine [Member] Exercisable term of warrant, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Fair value of warrants issued. Relative fair value of warrants recorded as discount to notes payable. Convertible Debt One [Member] The description of when the debt instrument was issued. Convertible Debt Two [Member] Convertible Debt Three [Member] Number of warrants issued during period. Annual base compensation owed to employee per employment agreement. Commission rate owed to employee expressed as percentage of sales. The expiration date of the employment contract. Employment Agreement [Member] Quarterly Information [Axis] Quarterly Information [Member] Expiration date of warrants. The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants outstanding. The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants outstanding. The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants granted during the period. The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants granted during the period. The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants cancelled during the period. The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants cancelled during the period. The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants exercisable. The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under equity instruments other than options and other required information pertaining to awards in the customized range for warrants exercisable. Weighted average remaining contractual term of exercisable equity instruments other than options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Value of outstanding convertible debentures and accrued interest that could be converted. Number of common shares reserved for possible future debt conversion. Number of common shares reserved for possible future warrant issuance and debt conversion. Repayment of accrued interest. Convertible Debentures Due 3rd Quarter 2017 [Member] Convertible Debentures Due 3rd Quarter 2016 [Member] Value of demand loans exchanged for convertible debt Value of demand loans from Director exchanged for convertible debt. Value of accrued interest on demand loans exchanged for convertible debt. Total value of convertible debt that accretion of debt discounts was recognized during the period. Additional value of convertible debt that accretion of debt discounts was recognized during the period. Amount of salary deferred by related party. Amount of deferred salary owed to related party. Portions of deferred salary paid to related party. Assets, Current Property, Plant and Equipment, Gross Property, Plant and Equipment, Net Assets [Default Label] Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues [Default Label] Cost of Services, Licenses and Services Cost of Goods Sold Cost of Revenue Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Weighted Average Number of Shares Outstanding, Diluted Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Deferred Revenue Increase (Decrease) in Operating Capital Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value [Abstract] NoncashInvestingActivitiesWriteoffOfLeaseholdImprovementsCost NoncashInvestingActivitiesWriteoffOfFurnitureFixturesAndEquipment IncreaseDecreaseInDemandLoansFromConversionToConvertibleDebenturesDueToNonCashFinancingActivity IncreaseDecreaseInAccruedExpensesFromConversionToConvertibleDebenturesDueToNonCashFinancingActivity IncreaseDecreaseInConvertibleDebenturesFromConversionToConvertibleDebenturesDueToNonCashFinancingActivity IncreaseDecreaseInPaidInCapitalFromConversionToConvertibleDebenturesDueToNonCashFinancingActivity IncreaseDecreaseInDemandLoansDueToNonCashFinancingActivity IncreaseDecreaseInAccruedExpensesDueToNonCashFinancingActivity IncreaseDecreaseInPaidInCapitalDueToNonCashFinancingActivity Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Revenue Recognition, Policy [Policy Text Block] Debt, Policy [Policy Text Block] DebtInstrumentIssuanceDateDescription Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice SharebasedCompensationSharesAuthorizedUnderEquityInstrumentsOtherThanOptionsExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm2 ShareBasedCompensationSharesAuthorizedUnderEquityInstrumentsOtherThanOptionsExercisePriceRangeDomain EX-101.PRE 10 nnup-20151231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2015
Mar. 15, 2016
Jun. 30, 2015
Document and Entity Information [Abstract]      
Entity Registrant Name NOCOPI TECHNOLOGIES INC/MD/    
Entity Central Index Key 0000888981    
Current Fiscal Year End Date --12-31    
Entity Filer Category Smaller Reporting Company    
Document Type 10-K    
Document Period End Date Dec. 31, 2015    
Document Fiscal Year Focus 2015    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Public Float     $ 519,000
Entity Common Stock Shares Outstanding   58,599,016  
Entity Well Known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
Balance Sheets - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Current assets    
Cash $ 11,400 $ 28,000
Accounts receivable less $5,000 allowance for doubtful accounts 253,300 287,800
Inventory 36,600 43,500
Prepaid and other 22,600 18,800
Total current assets 323,900 378,100
Fixed assets    
Leasehold improvements 19,700 19,700
Furniture, fixtures and equipment 176,900 176,800
Fixed assets, gross 196,600 196,500
Less: accumulated depreciation and amortization 175,700 178,400
Total fixed assets 20,900 18,100
Total assets 344,800 396,200
Current liabilities    
Demand loans 23,500 63,000
Convertible debentures 32,800 102,900
Accounts payable 76,200 160,300
Accrued expenses 443,000 383,000
Deferred revenue 112,400 93,400
Total current liabilities $ 687,900 $ 802,600
Commitments and contingencies
Convertible debentures, net of unaccreted discount of $0 at December 31, 2015 and $1,400 at December 31, 2014 $ 95,000 $ 31,800
Stockholders' deficiency    
Series A preferred stock, $1.00 par value, Authorized - 300,000 shares, Issued and outstanding - none
Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 58,599,016 shares $ 586,000 $ 586,000
Paid-in capital 12,426,600 12,408,500
Accumulated deficit (13,450,700) (13,432,700)
Total stockholders' deficiency (438,100) (438,200)
Total liabilities and stockholders' deficiency $ 344,800 $ 396,200
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900
Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 5,000 $ 5,000
Unaccreted discount on convertible debentures $ 1,400
Preferred stock, par value $ 1.00 $ 1.00
Preferred stock, shares authorized 300,000 300,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 58,599,016 58,599,016
Common stock, shares outstanding 58,599,016 58,599,016
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues    
Licenses, royalties and fees $ 338,700 $ 358,800
Product and other sales 612,100 564,000
Total revenues 950,800 922,800
Cost of revenues    
Licenses, royalties and fees 77,000 75,600
Product and other sales 256,000 248,700
Total cost of revenues 333,000 324,300
Gross profit 617,800 598,500
Operating expenses    
Research and development 128,100 121,600
Sales and marketing 202,800 194,500
General and administrative 325,600 253,400
Total operating expenses 656,500 569,500
Net income (loss) from operations (38,700) $ 29,000
Other income (expenses)    
Reversal of accounts payable $ 56,300
Interest income $ 300
Interest expense, bank charges, financing cost and accretion of interest $ (35,600) (21,600)
Total other income (expenses) 20,700 (21,300)
Net income (loss) $ (18,000) $ 7,700
Net income (loss) per common share    
Basic $ 0.00 $ 0.00
Diluted $ 0.00 $ 0.00
Weighted average common shares outstanding    
Basic 58,599,016 58,599,016
Diluted 58,599,016 58,600,690
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statement of Stockholders' Deficit - USD ($)
Common stock [Member]
Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2013 $ 586,000 $ 12,406,600 $ (13,440,400) $ (447,800)
Balance, shares at Dec. 31, 2013 58,599,016      
Fair value of warrants issued to convertible debenture holders   1,900   1,900
Net income (loss)     7,700 7,700
Balance at Dec. 31, 2014 $ 586,000 12,408,500 (13,432,700) $ (438,200)
Balance, shares at Dec. 31, 2014 58,599,016     58,599,016
Debt discount to convertible debentures   18,100   $ 18,100
Net income (loss)     (18,000) (18,000)
Balance at Dec. 31, 2015 $ 586,000 $ 12,426,600 $ (13,450,700) $ (438,100)
Balance, shares at Dec. 31, 2015 58,599,016     58,599,016
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating Activities    
Net income (loss) $ (18,000) $ 7,700
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation and amortization 6,100 $ 4,000
Reversal of accounts payable (56,300)
Accretion of interest - convertible debentures 21,200 $ 4,600
Net income (loss) adjusted for non-cash operating activities (47,000) 16,300
(Increase) decrease in assets    
Accounts receivable 34,500 (50,700)
Inventory 6,900 (15,000)
Prepaid and other (3,800) 12,700
Increase (decrease) in liabilities    
Accounts payable and accrued expenses 32,200 71,600
Deferred revenue 19,000 (20,400)
Total increase (decrease) in operating capital 88,800 (1,800)
Net cash provided by operating activities 41,800 14,500
Investing Activities    
Additions to fixed assets (8,900) (20,600)
Net cash used in investing activities $ (8,900) (20,600)
Financing Activities    
Repayment of borrowings under promissory note (18,800)
Repayment of demand loans $ (39,500) (5,000)
Proceeds from convertible debentures $ 5,000
Repayment of convertible debenture $ (10,000)
Net cash used in financing activities (49,500) $ (18,800)
Decrease in cash (16,600) (24,900)
Cash    
Beginning of year 28,000 52,900
End of year 11,400 28,000
Cash paid for interest 7,700 300
Write-off of fully depreciated leasehold improvements and furniture fixtures and equipment    
Accumulated depreciation and amortization $ (8,800) (82,900)
Leasehold improvements 72,500
Furniture, fixtures and equipment $ 8,800 10,400
Conversion of demand loans and interest to convertible debentures    
Demand loans (24,500)
Accrued expenses (3,800)
Convertible debentures 26,400
Paid-in capital $ 1,900
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Organization of the Company
12 Months Ended
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization of the Company

1.

Organization of the Company


Nocopi Technologies, Inc. (the “Company”) is organized under the laws of the State of Maryland. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the Entertainment and Toy and the Document and Product Authentication markets in the United States and foreign countries. The Company operates in one principal industry segment.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Significant Accounting Policies
12 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Significant Accounting Policies


2.

Significant Accounting Policies


Financial Statement Presentation - Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.


Estimates - The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.


Cash consists of demand deposits with a major U.S. bank.


Accounts receivable and credit policies - Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.


The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.


Inventory consists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or market.


Fixed assets are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.


Patent costs are charged to expense as incurred due to the uncertainty of their recoverability as a result of the Company’s adverse liquidity situation.


Revenues - In accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 605, Revenue Recognition, the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to these criteria, the Company will generally recognize revenue upon shipment of product. Revenue from license fees and royalties will be recognized as earned over the license term.


Income taxes - Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.


Fair value - The carrying amounts reflected in the balance sheets for cash, receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. The carrying amount of the demand loans and the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.


Convertible debentures, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.


Stock-based payments - the Company accounts for stock-based compensation under the provisions of FASB ASC 718, "Compensation - Stock Compensation" which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, "Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders’ equity over the applicable service periods. Non-employee equity based payments that do not vest immediately upon grant are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed.


Earnings (loss) per share - The Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share. Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.


The table below presents the computation of basic and diluted weighted average common shares outstanding:


 

 

2015

 

 

2014

 

Basic shares outstanding

 

 

58,599,016

 

 

 

58,599,016

 

Incremental shares from assumed conversion of warrants

 

 

 

 

 

1,674

 

Diluted shares outstanding

 

 

58,599,016

 

 

 

58,600,690

 


Comprehensive income (loss) - The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net income (loss).


Recoverability of Long-Lived Assets


The Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.  The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company’s annual financial statements.


Recently Adopted Accounting Pronouncements


As of December 31, 2015 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.


Recently Issued Accounting Pronouncements Not Yet Adopted


In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments in this Update provide guidance about management’s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued and to provide related footnote disclosures. Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management is assessing the impact of the adoption to the financial statements.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
Going Concern
12 Months Ended
Dec. 31, 2015
Going Concern [Abstract]  
Going Concern

3.

Going Concern


Since its inception, with the exception of the years ended December 31, 2007 and December 31, 2013 and December 13, 2014, during which it generated net income of $386,000 and $10,300 and $7,700, respectively, the Company has incurred significant losses and, as of December 31, 2015, had accumulated losses of $13,450,700. For the year ended December 31, 2015, the Company had a net loss from operations of $38,700. For the year ended December 31, 2014 Company’s had net income from operations of $29,000. The Company had negative working capital of $364,000 at December 31, 2015 and $424,500 at December 31, 2014. Due in part to uncertainties in the US economy, the Company, which is substantially dependent on its licensees to generate licensing revenues, may incur further operating losses and experience negative cash flow in the future. Achieving profitability and positive cash flow depends on the Company’s ability to generate and sustain significant increases in revenues and gross profits from its traditional business. There can be no assurances that the Company will be able to generate sufficient revenues and gross profits to sustain profitability and return to positive cash flow in the future.


During 2014, the Company sold a $5,000 convertible debenture to an investor. Receipt of funds in earlier periods from investors and from demand loan holders have allowed the Company to remain in operation through the current date. Management of the Company believes that it may need additional capital in the future both to fund investments needed to increase its operating revenues to levels that will sustain its operations and to fund operating deficits that it anticipates will continue until revenue increases from traditional and new product lines can be realized. There can be no assurances that the Company will be successful in obtaining sufficient additional capital, or if it does, that the additional capital will enable the Company to impact its revenues so as to have a material positive effect on the Company’s operations and cash flow. The Company believes that without additional capital, whether in the form of debt, equity or both, it may be forced to cease operations at an undetermined future date.


The Company’s independent registered public accountants have included a “going concern” explanatory paragraph in their audit report accompanying the 2015 financial statements. The paragraph states that the Company’s continuing working capital deficit raises substantial doubt about the Company’s ability to continue as a going concern and cautions that the financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
Concentration of Credit Risk
12 Months Ended
Dec. 31, 2015
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk

4.

Concentration of Credit Risk


Certain financial instruments potentially subject the Company to concentrations of credit risk.  These financial instruments consist primarily of cash and accounts receivables. At December 31, 2015, the Company did not have deposits with a financial institution that exceed the FDIC deposit insurance coverage of $250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Demand Loans
12 Months Ended
Dec. 31, 2015
Debt Disclosure [Abstract]  
Demand Loans

5.

Demand Loans


At December 31, 2015 and December 31, 2014 the Company had unsecured loans totaling $23,500 from two individuals and $63,000 from three individuals, respectively, outstanding. The loans bear interest at 8%. During the year ended December 31, 2015, the Company repaid $39,500 of the unsecured loans along with approximately $6,300 of accrued interest. During the year ended December 31, 2014, the Company repaid $5,000 of the unsecured loans.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Promissory Note
12 Months Ended
Dec. 31, 2015
Line of Credit Facility [Abstract]  
Promissory Note

6.

Promissory Note


In early July 2014, the Company repaid the $6,250 remaining balance of a $100,000 promissory note with a bank. The promissory note resulted from the conversion in September 2010 of an outstanding line of credit with the bank. The promissory note was payable in forty-eight equal monthly installments, beginning in October 2010, of $2,083, plus interest at the bank’s prime rate of interest plus 0.5%. The interest rate throughout the term of the promissory note was 3.75%.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900
Convertible Debentures
12 Months Ended
Dec. 31, 2015
Convertible Debt [Abstract]  
Convertible Debentures

7.

Convertible Debentures


At December 31, 2015, the Company had convertible debentures totaling $127,800 outstanding, of which $32,800 are due during the third quarter of 2016 and $95,000 are due during the third quarter of 2017. The convertible debentures bear interest at 7%. At the option of the lender, $95,000 principal of the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.025 per share and $32,800 principal of the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. In July 2015, the Company repaid, with interest, a $10,000 convertible debenture that had matured. During the third quarter of 2015, the Company’s Board of Directors approved and the holders of $95,000 of convertible debentures maturing during the third quarter of 2015 accepted an offer of extension whereby the maturity dates of the convertible debentures are extended for two years and the conversion rate of the debentures and accrued interest into Common Stock of the Company is reduced from $0.05 to $0.025. In accordance with FASB ASC 470, this modification of the convertible debentures was recorded as a debt discount to the notes payable of approximately $18,100 with an offsetting credit to additional-paid in capital. In the year ended December 31, 2015, the entire $18,100 was accreted through interest expense.


During the third quarter of 2014, the Company, with the approval of its Board of Directors, exchanged two demand loans totaling $24,500 including one demand loan in the amount of $4,500 held by Herman M. Gerwitz, a Director, along with approximately $3,800 of accrued interest for convertible debentures totaling approximately $28,300. The debentures bear interest at 7% and are due and payable two years from the date of issuance. At option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 141,365 shares of common stock of the Company at $0.02 per share to the debenture holders. The warrants are exercisable two years after issuance and expire seven years after issuance.


During the third quarter of 2014, the Company received $5,000 through the issuance of a convertible debenture to an investor. The debenture bears interest at 7% and is due and payable two years from the date of issuance. At option of the lender, the debenture and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 25,000 shares of the Company’s common stock at $0.02 per share to the holder of the debenture. The warrants are exercisable two years after issuance and expire seven years after issuance.


Additionally, the Company has warrants to purchase 525,000 shares of the Company’s common stock at $0.02 per share outstanding that were granted in conjunction with the issuance of $105,000 of convertible debentures to seven investors in 2013. The warrants are exercisable two years after issuance and expire seven years after issuance.


The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since the Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances is being accreted through interest expense over the term of the notes payable. For the years ended December 31, 2015 and December 31, 2014, approximately $3,100 and $4,600, respectively, was accreted through interest expense.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Deficiency
12 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Stockholders' Deficiency


8.

Stockholders' Deficiency


In July 2015, the common stock private placement was extended to December 31, 2016 by the Company’s Board of Directors.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900
Other Income (Expenses)
12 Months Ended
Dec. 31, 2015
Other Income and Expenses [Abstract]  
Other Income (Expenses)

9.

Other Income (Expenses)


Other income (expenses) includes, in 2015, the reversal of approximately $56,300 of accounts payable related to invoices received from 2001 through 2009 from a professional services business that provided legal services to the Company and an individual that provided consulting services to the Company in 2009 that the Company, with legal counsel, has determined to be no longer statutorily payable as the statute of limitations to bring claims has expired. Additionally, other income (expenses) includes interest on unsecured loans from five individuals, on convertible debentures held by ten investors and, in 2014, on funds borrowed under the Company’s promissory note with a bank. Also included in other income (expenses) is accretion of debt discounts related to the issuance of convertible debentures totaling $128,400 and, in 2015, the extension of the maturity dates of $95,000 of convertible debentures.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Income Taxes

10.

Income Taxes


There is no income tax benefit for the year ended December 31, 2015 due to the availability of net operating loss carryforwards (“NOL’s”) for which the Company had previously established a 100% valuation allowance for deferred tax assets due to the uncertainty of their recoverability. There is no provision for income taxes for the year ended December 31, 2014 due to the availability of net operating loss carryforwards. At December 31, 2015 and December 31, 2014, the Company had NOL’s approximating $4,627,000 and $4,601,000, respectively. The operating losses at December 31, 2015 are available to offset future taxable income; however, if not utilized, they expire in varying amounts through the year 2035. As a result of the sale of the Company's common stock in an equity offering in late 1997 and the issuance of additional shares, the amount of the NOL’s may be limited. Additionally, the utilization of these NOL’s, if available, to reduce future income taxes will depend on the generation of sufficient taxable income prior to their expiration. There were no material temporary differences for the years ended December 31, 2015 and December 31, 2014. The Company has established a 100% valuation allowance of approximately $1,943,000 and $1,933,000 at December 31, 2015 and December 31, 2014, respectively, for the deferred tax assets due to the uncertainty of their realization.


The Company has adopted the provisions of FASB ASC 740-10-50-15, “Unrecognized Tax Benefit Related Disclosures.” There were no unrecognized tax benefits as of the date of adoption and no unrecognized tax benefits at December 31, 2015. There was no change in unrecognized tax benefits during the year ended December 31, 2015 and there was no accrual for uncertain tax positions as of December 31, 2015.


There were no interest and penalties recognized in the statement of operations and in the balance sheet. Tax years from 2011 through 2015 remain subject to examination by U.S. federal and state tax jurisdictions.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions
12 Months Ended
Dec. 31, 2015
Related Party Transactions [Abstract]  
Related Party Transactions

11.

Related Party Transactions


In each of the years ended December 31, 2015 and December 31, 2014, Michael A. Feinstein, M.D., the Company’s Chairman of the Board and Chief Executive Officer, deferred $85,000 of salary owed to him under an employment agreement with the Company. At December 31, 2015 and December 31, 2014, Dr. Feinstein was owed $290,400 and $215,400, respectively, of salary that was deferred by him in response to the adverse liquidity experienced by the Company beginning in 2012. There are no formal terms or arrangements for repayment of the deferred salary. In December 2015 and January 2016, the Company made payments of $10,000 and $15,000, respectively, to Dr. Feinstein, representing a portion of amounts owed to him. There is no interest payable on the deferred salary.  

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies
12 Months Ended
Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

12.

Commitments and Contingencies


The Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2019.


Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at December 31, 2015 are: $46,200 – 2016; $47,400 – 2017; $48,600 – 2018 and $16,300 – 2019.


Total rental expense under operating leases was $44,800 and $45,100 in 2014 and 2015, respectively.


The Company has an employment agreement, expiring in May 2017, with Michael A. Feinstein, M.D., its Chairman of the Board and Chief Executive Officer. The employment agreement contains one-year renewal provisions that became effective after the original term. Dr. Feinstein receives base compensation of $85,000 per year plus a performance bonus determined by the Company’s Board of Directors. The Company has an employment agreement, expiring in March 2017, with Terry W. Stovold, its Chief Operating Officer, whereby Mr. Stovold receives a salary set by the Company’s Board of Directors, currently set at $75,000, along with a commission of seven percent on sales generated by his efforts. The employment agreement contains one-year renewal provisions that became effective after the original term. Future minimum compensation payments under these employment agreements are: $160,000 to be paid in 2016 and $54,200 to be paid in 2017.


From time to time, the Company may be subject to legal proceedings and claims that arise in the ordinary course of its business.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Options, Warrants and 401(k) Savings Plan
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options, Warrants and 401(k) Savings Plan

13.

Stock Options, Warrants and 401(k) Savings Plan


The Company follows FASB ASC 718, Share Based Payment, which requires that the cost resulting from all share-based payment transactions be recognized in the Company’s financial statements. FASB ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values.


The 1999 Stock Option Plan provided for the granting of up to 2,000,000 incentive and non-qualified stock options to employees, non-employee directors, consultants and advisors to the Company. In the case of options designated as incentive stock options, the exercise price of the options granted must be not less than the fair market value of such shares on the date of grant. Non-qualified stock options may be granted at any amount established by the Stock Option Committee or, in the case of Discounted Options issued to non-employee directors in lieu of any portion of an Annual Retainer, in accordance with a formula designated in the Plan. The 1999 Stock Option Plan terminated in February 2009 and no further stock options can be granted under the plan; however, options granted before the termination date could be exercised through their expiration date.


The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no compensation expense recognized during the years ended December 31, 2015 and December 31, 2014 and there was no unrecognized portion of expense at December 31, 2015.


A summary of stock options under the Company’s stock option plans follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2013

 

245,000

 

 

0.12

 

 

0.12

 

Options expired

 

245,000

 

 

0.12

 

 

0.12

 

Outstanding at December 31, 2014 and 2015

 

0

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

  

 

 

Option

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

 

 

 

 

 

 

 

Exercisable options at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options available for future grant:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

0

 

 

 

 

 

 

 

 

 


At December 31, 2015, the Company had 756,365 warrants to purchase common stock of the Company outstanding at exercise prices ranging from $0.01 to $0.07 and expiring at various dates through July 2021. The warrants are held by ten investors who acquired convertible debentures from the Company in 2013 and 2014 and by three individuals who provided loans and professional services to the Company.


A summary of outstanding warrants follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2013

 

660,500

 

 

0.01 to 0.07

 

 

0.026

 

Warrants granted

 

166,365

 

 

0.02

 

 

0.02

 

Warrants canceled

 

24,500

 

 

0.03 and 0.07

 

 

0.037

 

Outstanding at December 31, 2014

 

802,365

 

 

0.01 to 0.07

 

 

0.025

 

Warrants expired

 

46,000

 

 

0.06 and 0.07

 

 

0.068

 

Outstanding at December 31, 2015

 

756,365

 

 

$0.01 to $0.07

 

 

$0.022

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

4.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Exercise

 

 

 

Average

 

 

 

 

 

 

 

Price Range

 

 

 

Exercise

 

 

 

Shares

 

 

 

Per Share

 

 

 

Price

 

Exercisable warrants at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

590,000

 

 

$0.01 to $0.07

 

 

$0.023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

4.23

 

 

 

 

 

 

 

 

 


At December 31, 2015, the Company has reserved 5,846,989 shares of common stock for possible future issuance upon exercise of 756,365 warrants and for the conversion of approximately $128,300 of convertible debentures and accrued interest into 5,090,624 shares of common stock.


The Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of the Company. There were no contributions charged to expense during 2015 or 2014.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Major Customer and Geographic Information
12 Months Ended
Dec. 31, 2015
Major Customer and Geographic Information [Abstract]  
Major Customer and Geographic Information

14.

Major Customer and Geographic Information


The Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were:


 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

Customer A

 

 

53

%

 

 

47

%

Customer B

 

 

17

%

 

 

19

%


The Company’s non-affiliate customers whose individual balances amounted to more than 10% of the Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:


 

 

December 31

 

 

 

2015

 

 

2014

 

 Customer A

 

 

31

%

 

 

46

%

 Customer B

 

 

25

%

 

 

35

%


The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on the Company’s business operations and financial condition.


The Company’s revenues by geographic region are as follows:


 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

North America

 

$

433,000

 

 

$

477,100

 

Asia

 

 

511,600

 

 

 

445,700

 

Australia

 

 

6,200

 

 

 

 

 

 

$

950,800

 

 

$

922,800

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsequent Events
12 Months Ended
Dec. 31, 2015
Subsequent Events [Abstract]  
Subsequent Event

15.

Subsequent Event


In March 2016, the Company repaid $4,000 of the principal of the outstanding demand loans.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Financial Statement Presentation

Financial Statement Presentation - Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.

Estimates

Estimates - The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.

Cash

Cash consists of demand deposits with a major U.S. bank.

Accounts receivable and credit policies

Accounts receivable and credit policies - Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.


The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.

Inventory

Inventory consists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or market.

Fixed assets


Fixed assets are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.

Patent costs

Patent costs are charged to expense as incurred due to the uncertainty of their recoverability as a result of the Company’s adverse liquidity situation.

Revenues

Revenues - In accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 605, Revenue Recognition, the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to these criteria, the Company will generally recognize revenue upon shipment of product. Revenue from license fees and royalties will be recognized as earned over the license term.

Income taxes

Income taxes - Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Fair value

Fair value - The carrying amounts reflected in the balance sheets for cash, receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. The carrying amount of the demand loans and the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.

Convertible debentures

Convertible debentures, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.

Stock-based payments

Stock-based payments - the Company accounts for stock-based compensation under the provisions of FASB ASC 718, "Compensation - Stock Compensation" which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, "Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders’ equity over the applicable service periods. Non-employee equity based payments that do not vest immediately upon grant are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed.

Earnings (loss) per share

Earnings (loss) per share - The Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share. Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.


The table below presents the computation of basic and diluted weighted average common shares outstanding:


 

 

2015

 

 

2014

 

Basic shares outstanding

 

 

58,599,016

 

 

 

58,599,016

 

Incremental shares from assumed conversion of warrants

 

 

 

 

 

1,674

 

Diluted shares outstanding

 

 

58,599,016

 

 

 

58,600,690

 

Comprehensive income (loss)

Comprehensive income (loss) - The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net income (loss).

Recoverability of Long-Lived Assets

Recoverability of Long-Lived Assets


The Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.  The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company’s annual financial statements.

Recently Adopted Accounting Pronouncements


Recently Adopted Accounting Pronouncements


As of December 31, 2015 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

Recently Issued Accounting Pronouncements Not Yet Adopted


In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments in this Update provide guidance about management’s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued and to provide related footnote disclosures. Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management is assessing the impact of the adoption to the financial statements.

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Weighted Average Common Shares Outstanding

The table below presents the computation of basic and diluted weighted average common shares outstanding:


 

 

2015

 

 

2014

 

Basic shares outstanding

 

 

58,599,016

 

 

 

58,599,016

 

Incremental shares from assumed conversion of warrants

 

 

 

 

 

1,674

 

Diluted shares outstanding

 

 

58,599,016

 

 

 

58,600,690

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Options, Warrants and 401(k) Savings Plan (Tables)
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Option Activity

A summary of stock options under the Company’s stock option plans follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2013

 

245,000

 

 

0.12

 

 

0.12

 

Options expired

 

245,000

 

 

0.12

 

 

0.12

 

Outstanding at December 31, 2014 and 2015

 

0

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

  

 

 

Option

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

 

 

 

 

 

 

 

Exercisable options at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options available for future grant:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

0

 

 

 

 

 

 

 

 

 

Schedule of Warrants Outstanding

A summary of outstanding warrants follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2013

 

660,500

 

 

0.01 to 0.07

 

 

0.026

 

Warrants granted

 

166,365

 

 

0.02

 

 

0.02

 

Warrants canceled

 

24,500

 

 

0.03 and 0.07

 

 

0.037

 

Outstanding at December 31, 2014

 

802,365

 

 

0.01 to 0.07

 

 

0.025

 

Warrants expired

 

46,000

 

 

0.06 and 0.07

 

 

0.068

 

Outstanding at December 31, 2015

 

756,365

 

 

$0.01 to $0.07

 

 

$0.022

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

4.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Exercise

 

 

 

Average

 

 

 

 

 

 

 

Price Range

 

 

 

Exercise

 

 

 

Shares

 

 

 

Per Share

 

 

 

Price

 

Exercisable warrants at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

590,000

 

 

$0.01 to $0.07

 

 

$0.023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

4.23

 

 

 

 

 

 

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Major Customer and Geographic Information (Tables)
12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Schedule of Revenues from Non-affiliated Customers

The Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were:


 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

Customer A

 

 

53

%

 

 

47

%

Customer B

 

 

17

%

 

 

19

%

Schedule of Non-affiliated Customers with Accounts Receivable More Than 10%

The Company’s non-affiliate customers whose individual balances amounted to more than 10% of the Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:


 

 

December 31

 

 

 

2015

 

 

2014

 

 Customer A

 

 

31

%

 

 

46

%

 Customer B

 

 

25

%

 

 

35

%

Schedule of Revenue by Geographic Region

The Company’s revenues by geographic region are as follows:


 

 

Year ended December 31

 

 

 

2015

 

 

2014

 

North America

 

$

433,000

 

 

$

477,100

 

Asia

 

 

511,600

 

 

 

445,700

 

Australia

 

 

6,200

 

 

 

 

 

 

$

950,800

 

 

$

922,800

 

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Significant Accounting Policies (Schedule of Basic and Diluted Weighted Average Common Shares Outstanding) (Details) - shares
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Accounting Policies [Abstract]    
Basic shares outstanding 58,599,016 58,599,016
Incremental shares from assumed conversion of stock options and warrants 1,674
Diluted shares outstanding 58,599,016 58,600,690
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
Going Concern (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2007
Going Concern [Abstract]          
Net loss (income) $ 18,000 $ (7,700) $ (10,300)   $ (386,000)
Accumulated deficit 13,450,700 13,432,700      
Working capital deficit 364,000 424,500      
Operating loss (income) $ 38,700 (29,000) 12,900 $ 143,800  
Proceeds from convertible debentures $ 5,000 $ 105,000  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Concentration of Credit Risk (Details)
Dec. 31, 2015
USD ($)
Risks and Uncertainties [Abstract]  
Amount of cash unisured by FDIC $ 0
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900
Demand Loans (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Short-term Debt [Line Items]    
Repayments of demand loans $ 39,500 $ 5,000
Unsecured Loan [Member]    
Short-term Debt [Line Items]    
Debt instrument, face amount $ 23,500 $ 63,000
Debt instrument, interest rate 8.00% 8.00%
Repayments of demand loans $ 39,500 $ 5,000
Repayment of accrued interest $ 6,300  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900
Promissory Note (Details) - Revolving Line of Credit [Member] - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2014
Sep. 30, 2010
Dec. 31, 2008
Dec. 31, 2009
Line of Credit Facility [Line Items]        
Revolving line of credit, interest rate     3.75%  
Revolving line of credit, basis spread over prime rate     0.50%  
Revolving line of credit, amount outstanding       $ 100,000
Amount of monthly installment payments of principal, plus interest to repay line of credit facility   $ 2,083    
Re-payment terms of line of credit facility   Forty-eight equal monthly installments    
Revolving line of credit, required first payment date   Oct. 01, 2010    
Repayment of line of credit $ 6,250      
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Convertible Debentures (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2015
Sep. 30, 2015
Dec. 31, 2015
Dec. 31, 2014
Debt Instrument [Line Items]        
Repayments of convertible debenture     $ 10,000
Interest expense     $ 35,600 $ 21,600
Debt discount recognized on notes payable     1,400
Convertible Debt [Member]        
Debt Instrument [Line Items]        
Debt instrument, face amount     $ 127,800  
Debt instrument, interest rate     7.00%  
Convertible debt due during the third quarter of 2016     $ 32,800  
Convertible debt due during the third quarter of 2017     $ 95,000  
Repayments of convertible debenture $ 10,000      
Price per share of warrants     $ 0.02  
Warrant exercisable term     2 years  
Warrant expiration term     7 years  
Debt discount recognized on notes payable $ 18,100      
Accretion of debt discount recognized as interest expense     $ 18,100  
Convertible Debt [Member] | Convertible Debt Due Third Quarter 2016 [Member]        
Debt Instrument [Line Items]        
Debt instrument, interest rate     7.00%  
Debt instrument, conversion price per share     $ 0.05  
Convertible debt due during the third quarter of 2016     $ 32,800  
Convertible Debt [Member] | Convertible Debt Due Third Quarter 2017 [Member]        
Debt Instrument [Line Items]        
Debt instrument, interest rate     7.00%  
Debt instrument, maturity date   extended for two years    
Debt instrument, conversion price per share   $ 0.025 $ 0.025  
Convertible debt due during the third quarter of 2017     $ 95,000  
Convertible Debt [Member] | Convertible Debt Issued to Seven Investors during 2013 [Member]        
Debt Instrument [Line Items]        
Debt instrument, face amount     $ 105,000  
Debt instrument, issuance date     During third quarter 2013  
Number of shares of common stock that can be purchased through warrants     525,000  
Price per share of warrants     $ .02  
Warrant exercisable term     2 years  
Warrant expiration term     7 years  
Pricing model used to value warrants     Black-Scholes pricing model  
Interest expense     $ 3,100 $ 4,600
Convertible Debt [Member] | Convertible Debt Issued to Investor During Third Quarter 2014 [Member]        
Debt Instrument [Line Items]        
Debt instrument, face amount     $ 5,000  
Debt instrument, issuance date     During third quarter 2014  
Debt instrument, interest rate     7.00%  
Debt instrument, maturity date     Two years from date of issuance  
Debt instrument, conversion price per share     $ .05  
Number of shares of common stock that can be purchased through warrants     25,000  
Price per share of warrants     $ 0.02  
Warrant exercisable term     2 years  
Warrant expiration term     7 years  
Convertible Debt [Member] | Convertible Debt Exchanged For Two Demand Loans [Member]        
Debt Instrument [Line Items]        
Debt instrument, face amount     $ 28,300  
Debt instrument, issuance date     During third quarter 2014  
Debt instrument, interest rate     7.00%  
Debt instrument, maturity date     Two years from date of issuance  
Debt instrument, conversion price per share     $ 0.05  
Number of shares of common stock that can be purchased through warrants     141,365  
Price per share of warrants     $ .02  
Warrant exercisable term     2 years  
Warrant expiration term     7 years  
Value of demand loans exchanged for convertible debt     $ 24,500  
Value of demand loans from Director exchanged for convertible debt     4,500  
Value of accrued interest on demand loans exchanged for convertible debt     $ 3,800  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Other Income (Expenses) (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Other Income and Expenses [Abstract]    
Reversal of accounts payable $ 56,300
Total value of convertible debt that accretion of debt discounts was recognized during the period 128,400  
Additional value of convertible debt that accretion of debt discounts was recognized during the period $ 95,000  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating Loss Carryforwards [Line Items]    
Income tax provision
Net operating loss carryforwards $ 4,627,000 $ 4,601,000
Deferred tax assets, valuation allowance $ 1,943,000 $ 1,933,000
Unrecognized tax benefits
Change in unrecognized tax benefits during the period  
Accrual for uncertain tax positions
Interest and penalties from tax examinations recognized in the statement of operations
Interest and penalties from tax examinations recognized on the balance sheet
Minimum [Member]    
Operating Loss Carryforwards [Line Items]    
Tax years open for examination 2011  
Maximum [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carryforwards, expiration date Dec. 31, 2035  
Tax years open for examination 2015  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions (Details) - Chief Executive Officer [Member] - USD ($)
1 Months Ended 12 Months Ended
Jan. 31, 2016
Dec. 31, 2015
Dec. 31, 2015
Dec. 31, 2014
Related Party Transaction [Line Items]        
Amount of salary deferred by related party     $ 85,000 $ 85,000
Amount of deferred salary owed to related party   $ 290,400 $ 290,400 $ 215,400
Portions of deferred salary paid to related party   $ 10,000    
Subsequent Event [Member]        
Related Party Transaction [Line Items]        
Portions of deferred salary paid to related party $ 15,000      
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies (Operating Leases) (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]    
Lease expiration date Dec. 31, 2019  
Future minimum payments due under operating leases:    
2016 $ 46,200  
2017 47,400  
2018 48,600  
2019 16,300  
Total rent expense under operating lease agreement $ 45,100 $ 44,800
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies (Employment Agreements) (Details) - Employment Agreement [Member]
12 Months Ended
Dec. 31, 2015
USD ($)
Other Commitments [Line Items]  
Future minimum compensation payments due 2016 $ 160,000
Future minimum compensation payments due 2017 $ 54,200
Chief Executive Officer [Member]  
Other Commitments [Line Items]  
Employment contract, expiration date 2017-05
Annual base compensation owed to employee per employment agreement $ 85,000
Chief Operating Officer [Member]  
Other Commitments [Line Items]  
Employment contract, expiration date 2017-03
Annual base compensation owed to employee per employment agreement $ 75,000
Commission rate owed to employee expressed as percentage of sales 7.00%
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Options, Warrants and 401(k) Savings Plan (Narrative) (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares authorized under plan 2,000,000  
Method used to value the grant date fair value of awards Black-Scholes option pricing model  
Compensation expense from options not yet recognized
Shares remaining available for grant  
Employer contributions for 401(k) savings plan charged to expense during period
Stock option compensation expense recognized
Number of common shares reserved for possible future warrant issuance and debt conversion 5,846,989  
Value of outstanding convertible debentures and accrued interest that could be converted $ 128,300  
Number of common shares reserved for possible future debt conversion 5,090,624  
Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrants expiration date 2021-07  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Options, Warrants and 401(k) Savings Plan (Summary of Stock Option Activity) (Details) - $ / shares
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Number of Shares    
Options outstanding at beginning of period 245,000
Options expired 245,000
Options outstanding at end of period
Options exercisable at end of period  
Weighted Average Exercise Price    
Options outstanding at beginning of period $ 0.12
Options expired   $ 0.12
Options outstanding at end of period
Weighted average remaining contractual life 0 years  
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Options, Warrants and 401(k) Savings Plan (Summary of Warrants Activity) (Details) - Warrant [Member] - $ / shares
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Warrants    
Warrants outstanding at beginning of period 802,365 660,500
Granted 0 166,365
Cancelled/Expired 46,000 24,500
Warrants outstanding at end of period 756,365 802,365
Price    
Warrants outstanding at beginning of period $ 0.025 $ 0.026
Granted   0.02
Cancelled/Expired 0.068 0.037
Warrants outstanding at end of period $ 0.022 $ 0.025
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Options and Warrants (Summary of Warrants Outstanding by Price Range) (Details) - Warrant [Member] - $ / shares
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options Exercise Price Range [Line Items]      
Warrants outstanding exercise price range, lower limit $ 0.01 $ 0.01 $ 0.01
Warrants outstanding exercise price range, upper limit 0.07 0.07 $ 0.07
Warrants granted exercise price range, upper limit   0.02  
Warrants expired/cancelled exercise price range, lower limit 0.06 0.03  
Warrants expired/cancelled exercise price range, upper limit 0.07 $ 0.07  
Warrants exercisable exercise price range, lower limit 0.01    
Warrants exercisable exercise price range, upper limit $ 0.07    
Weighted average remaining contractual life 4 years 6 months 4 days    
Number exercisable 590,000    
Weighted average exercise price, exercisable $ 0.023    
Warrants exercisable, weighted average remaining contractual life 4 years 2 months 23 days    
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) - Revenue [Member]
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Customer A [Member]    
Revenue, Major Customer [Line Items]    
Risk percentage 53.00% 47.00%
Customer B [Member]    
Revenue, Major Customer [Line Items]    
Risk percentage 17.00% 19.00%
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) - Accounts Receivable [Member]
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Customer A [Member]    
Concentration Risk [Line Items]    
Risk percentage 31.00% 46.00%
Customer B [Member]    
Concentration Risk [Line Items]    
Risk percentage 25.00% 35.00%
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900
Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues $ 950,800 $ 922,800
North America [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 433,000 477,100
Asia [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 511,600 $ 445,700
Australia [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues $ 6,200
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsequent Events (Details) - USD ($)
1 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Subsequent Event [Line Items]      
Repayments of outstanding demand loans   $ 39,500 $ 5,000
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Repayments of outstanding demand loans $ 4,000    
EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 56 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 80 223 1 false 26 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://xbrl.nocopi.com/20111231/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://xbrl.nocopi.com/20111231/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://xbrl.nocopi.com/role/ConsolidatedBalanceSheetsParentheticals Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations Sheet http://xbrl.nocopi.com/20111231/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Statement of Stockholders' Deficit Sheet http://xbrl.nocopi.com/role/StatementOfStockholdersDeficit Statement of Stockholders' Deficit Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows Sheet http://xbrl.nocopi.com/20111231/role/StatementsOfCashFlows Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Organization of the Company Sheet http://xbrl.nocopi.com/role/OrganizationOfCompany Organization of the Company Notes 7 false false R8.htm 00000008 - Disclosure - Significant Accounting Policies Sheet http://xbrl.nocopi.com/20111231/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://xbrl.nocopi.com/20111231/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Concentration of Credit Risk Sheet http://xbrl.nocopi.com/20111231/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 10 false false R11.htm 00000011 - Disclosure - Demand Loans Sheet http://xbrl.nocopi.com/role/DemandLoans Demand Loans Notes 11 false false R12.htm 00000012 - Disclosure - Promissory Note Sheet http://xbrl.nocopi.com/role/PromissoryNote Promissory Note Notes 12 false false R13.htm 00000013 - Disclosure - Convertible Debentures Sheet http://xbrl.nocopi.com/role/ConvertibleDebentures Convertible Debentures Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders' Deficiency Sheet http://xbrl.nocopi.com/20111231/role/StockholdersDeficiency Stockholders' Deficiency Notes 14 false false R15.htm 00000015 - Disclosure - Other Income (Expenses) Sheet http://xbrl.nocopi.com/20111231/role/OtherIncomeExpenses Other Income (Expenses) Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://xbrl.nocopi.com/20111231/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Related Party Transactions Sheet http://xbrl.nocopi.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Commitments and Contingencies Sheet http://xbrl.nocopi.com/20111231/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan Sheet http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlan Stock Options, Warrants and 401(k) Savings Plan Notes 19 false false R20.htm 00000020 - Disclosure - Major Customer and Geographic Information Sheet http://xbrl.nocopi.com/20111231/role/MajorCustomerAndGeographicInformation Major Customer and Geographic Information Notes 20 false false R21.htm 00000021 - Disclosure - Subsequent Events Sheet http://xbrl.nocopi.com/20111231/role/SubsequentEvent Subsequent Events Notes 21 false false R22.htm 00000023 - Disclosure - Significant Accounting Policies (Policies) Sheet http://xbrl.nocopi.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://xbrl.nocopi.com/20111231/role/SignificantAccountingPolicies 22 false false R23.htm 00000024 - Disclosure - Significant Accounting Policies (Tables) Sheet http://xbrl.nocopi.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://xbrl.nocopi.com/20111231/role/SignificantAccountingPolicies 23 false false R24.htm 00000025 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Tables) Sheet http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanTables Stock Options, Warrants and 401(k) Savings Plan (Tables) Tables http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlan 24 false false R25.htm 00000026 - Disclosure - Major Customer and Geographic Information (Tables) Sheet http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationTables Major Customer and Geographic Information (Tables) Tables http://xbrl.nocopi.com/20111231/role/MajorCustomerAndGeographicInformation 25 false false R26.htm 00000028 - Disclosure - Significant Accounting Policies (Schedule of Basic and Diluted Weighted Average Common Shares Outstanding) (Details) Sheet http://xbrl.nocopi.com/role/SignificantAccountingPoliciesScheduleOfBasicAndDilutedWeightedAverageCommonSharesOutstandingDetails Significant Accounting Policies (Schedule of Basic and Diluted Weighted Average Common Shares Outstanding) (Details) Details http://xbrl.nocopi.com/role/SignificantAccountingPoliciesTables 26 false false R27.htm 00000029 - Disclosure - Going Concern (Details) Sheet http://xbrl.nocopi.com/role/GoingConcernDetails Going Concern (Details) Details http://xbrl.nocopi.com/20111231/role/GoingConcern 27 false false R28.htm 00000030 - Disclosure - Concentration of Credit Risk (Details) Sheet http://xbrl.nocopi.com/role/ConcentrationOfCreditRiskDetails Concentration of Credit Risk (Details) Details http://xbrl.nocopi.com/20111231/role/ConcentrationOfCreditRisk 28 false false R29.htm 00000031 - Disclosure - Demand Loans (Details) Sheet http://xbrl.nocopi.com/role/DemandLoansDetails Demand Loans (Details) Details http://xbrl.nocopi.com/role/DemandLoans 29 false false R30.htm 00000032 - Disclosure - Promissory Note (Details) Sheet http://xbrl.nocopi.com/role/PromissoryNoteDetails Promissory Note (Details) Details http://xbrl.nocopi.com/role/PromissoryNote 30 false false R31.htm 00000033 - Disclosure - Convertible Debentures (Details) Sheet http://xbrl.nocopi.com/role/ConvertibleDebenturesDetails Convertible Debentures (Details) Details http://xbrl.nocopi.com/role/ConvertibleDebentures 31 false false R32.htm 00000034 - Disclosure - Other Income (Expenses) (Details) Sheet http://xbrl.nocopi.com/role/OtherIncomeExpensesDetails Other Income (Expenses) (Details) Details http://xbrl.nocopi.com/20111231/role/OtherIncomeExpenses 32 false false R33.htm 00000035 - Disclosure - Income Taxes (Details) Sheet http://xbrl.nocopi.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://xbrl.nocopi.com/20111231/role/IncomeTaxes 33 false false R34.htm 00000036 - Disclosure - Related Party Transactions (Details) Sheet http://xbrl.nocopi.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://xbrl.nocopi.com/role/RelatedPartyTransactions 34 false false R35.htm 00000037 - Disclosure - Commitments and Contingencies (Operating Leases) (Details) Sheet http://xbrl.nocopi.com/role/CommitmentsAndContingenciesOperatingLeasesDetails Commitments and Contingencies (Operating Leases) (Details) Details http://xbrl.nocopi.com/20111231/role/CommitmentsAndContingencies 35 false false R36.htm 00000038 - Disclosure - Commitments and Contingencies (Employment Agreements) (Details) Sheet http://xbrl.nocopi.com/role/CommitmentsAndContingenciesEmploymentAgreementsDetails Commitments and Contingencies (Employment Agreements) (Details) Details http://xbrl.nocopi.com/20111231/role/CommitmentsAndContingencies 36 false false R37.htm 00000039 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Narrative) (Details) Sheet http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanNarrativeDetails Stock Options, Warrants and 401(k) Savings Plan (Narrative) (Details) Details http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanTables 37 false false R38.htm 00000040 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Summary of Stock Option Activity) (Details) Sheet http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanSummaryOfStockOptionActivityDetails Stock Options, Warrants and 401(k) Savings Plan (Summary of Stock Option Activity) (Details) Details http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanTables 38 false false R39.htm 00000041 - Disclosure - Stock Options, Warrants and 401(k) Savings Plan (Summary of Warrants Activity) (Details) Sheet http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanSummaryOfWarrantsActivityDetails Stock Options, Warrants and 401(k) Savings Plan (Summary of Warrants Activity) (Details) Details http://xbrl.nocopi.com/role/StockOptionsWarrantsAnd401kSavingsPlanTables 39 false false R40.htm 00000042 - Disclosure - Stock Options and Warrants (Summary of Warrants Outstanding by Price Range) (Details) Sheet http://xbrl.nocopi.com/role/StockOptionsAndWarrantsSummaryOfWarrantsOutstandingByPriceRangeDetails Stock Options and Warrants (Summary of Warrants Outstanding by Price Range) (Details) Details 40 false false R41.htm 00000043 - Disclosure - Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) Sheet http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationScheduleOfRevenuesFromNon-affiliatedCustomersDetails Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) Details http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationTables 41 false false R42.htm 00000044 - Disclosure - Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) Sheet http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationScheduleOfNon-affiliatedCustomersWithAccountsReceivableMoreThan10Details Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) Details http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationTables 42 false false R43.htm 00000045 - Disclosure - Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) Sheet http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationScheduleOfRevenueByGeographicRegionDetails Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) Details http://xbrl.nocopi.com/role/MajorCustomerAndGeographicInformationTables 43 false false R44.htm 00000046 - Disclosure - Subsequent Events (Details) Sheet http://xbrl.nocopi.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://xbrl.nocopi.com/20111231/role/SubsequentEvent 44 false false All Reports Book All Reports nnup-20151231.xml nnup-20151231.xsd nnup-20151231_cal.xml nnup-20151231_def.xml nnup-20151231_lab.xml nnup-20151231_pre.xml true true ZIP 61 0001553350-16-001790-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001553350-16-001790-xbrl.zip M4$L#!!0 ( '1+?DC�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end